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Leydig cells (LCs) are found within the interstitium of the testes. LCs are crucial to male 
reproductive function due to their role in testosterone synthesis, a process vital for both 
organogenesis and secondary sex characteristic development. The generation of LCs differs 
between foetal and adult testes. During embryonic development, LCs differentiate from 
progenitors, their numbers peaking at embryonic day 15.5 (E15.5), then degenerating at birth. 
Postnatally, the stem LC (SLC) population is activated at puberty, providing the precursor pool 
where the adult LCs (ALCs) will later differentiate from. The exact mechanisms of this process 
are not well understood. The LIM homeobox 9 gene, Lhx9, is essential for the formation of the 
gonad, it is also expressed later in development in the testes interstitium in both foetal and adult 
LCs. The functional role of Lhx9 associated with this expression has been poorly characterised. 
We hypothesise that the Lhx9 is vital for forming the progenitor population from which LCs 
later differentiate. The effect of Lhx9 loss on the foetal or adult LC pools has not been studied.  
 
Gene expression was compared between Lhx9+/+ (WT) and Lhx9+/- (HET) mouse testes at two 
stages: E15.5 (using RT-qPCR), and adult (RNA-Sequencing). In the adult testes, 51 genes 
were found to be differentially expressed between the WT and HET mice. Additionally, gene 
ontology analysis revealed enrichment for genes involved in lipid metabolism. This pathway 
is utilised by LCs for testosterone production. At E15.5, expression of marker genes for 
progenitor stem cell populations, such as Nestin and Notch, was significantly reduced in the 
HET testes compared to the WT littermates. Conversely, steroidogenesis genes showed a 
significant increase in expression; supporting the hypothesis that Lhx9 acts to maintain the LC 
progenitor population in the testes. 
 
Treatment of testes with ethane dimethanesulfonate (EDS) in vivo causes the death of Leydig 
cells, allowing analysis of their regenerative capability. Preliminary results of qPCR analysis 
following EDS treatment in adult HET and WT testes shows altered expression of a few genes, 
such as a decrease in Nestin in EDS treated HET mice. Together, these results will not only 
provide further understanding of the role of Lhx9 in foetal and adult testis, but additionally help 
illustrate delicate balance of progenitor populations and their impact on secondary sex 
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Reproduction is key to the survival of all species, sexual reproduction in particular allows for 
genetic variation within a species and subsequently an increased chance of species survival 
over time. For animals, reproduction is a biologically instinctive process which seldom fails – 
this misconception commonly transfers across to our current understanding of human 
reproduction. An estimated 40-50% of all cases of infertility in humans are expected to be a 
result of “male infertility”, whereby one or more factors, whether lifestyle or genetic, that 
contribute to the reproductive health of the male result in unsuccessful conception 
(Durairajanayagam, 2018; Ferlin et al., 2006). Factors can include insufficient sperm, abnormal 
sperm morphology, or poor sperm motility (Kumar & Singh, 2015). The effects of infertility 
can have tremendously negative social and mental implications on individuals. Attention 
towards male infertility can be focused too intently on recently impaired adult function, 
neglecting potential issues which may arise earlier in embryonic development. The 
development of the reproductive system is complex both anatomically and genetically, 
abnormalities which may arise in the embryonic cell populations can have large impacts on 
adult fertility. This poorly explored area highlights the need for more focused research. 
 
1.1. Urogenital Ridge Development 
The urogenital ridge (UGR) is the term assigned to the precursor tissue of the kidneys and 
gonads. It is derived from the intermediate mesoderm, one of the three primary germ layers in 
the developing embryo that form after gastrulation (Armstrong et al., 1993). The initial stages 
of genital ridge development are the same for both sexes. The UGR proliferates during early 
development at approximately embryonic day 9.5 (E9.5) in the mouse to form two bilateral 
thickenings of epithelial tissue on the posterior wall of the coelomic cavity (Armstrong et al., 
1993; Staack et al., 2003). During this period of development, the UGR is being colonised by 
primordial germ cells (PGCs), the precursors of sperm and oocytes. The PGCs migrate along 
the hindgut and reach the final destination of the gonad at E10.5 in the mouse (Molyneaux et 
al., 2001; Rey et al., 2016). The UGR is bipotential at this time, maintaining the ability to 
differentiate into one of two fates dependant on the genetic influences of the combination of 
the X and Y sex determining chromosomes.  
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1.2. Male Sex Determination and Testicular Development  
 Anatomical Development 
Structural changes arise during testicular development with an evolving gene expression 
profile. Key genes involved are outlined in Table 1. As Sertoli cells develop, anatomically, the 
seminiferous tubule structure of the testis forms through the process of cellular partitioning. 
Here, the endothelial cells originating from the surrounding vascular plexus of the 
mesonephros create a physical barrier between the germ cells and Sertoli cells i.e. defining the 
interstitium and tubules (Defalco et al., 2014). As the network of tubules begin to expand, an 
extracellular matrix is deposited by the Sertoli cells into the interstitium, and the physical 
barrier becomes a layer of peritubular myoid cells (Das et al., 2011; Hadley et al., 1985). 
 
Leydig cells (LCs) begin to form at around E11.5-12.5 in the embryonic testes, secreting 
testosterone, the hormone critical for the maintenance of the Wolffian duct and mesonephric 
tubules. (Murashima et al., 2011). This enables structural evolution in the testis, more 
specifically, the development of the epididymis, vas deferens, and seminal vesicles, eventually 
contributing to a fully developed testis (Pointis et al., 1980; Rey et al., 2016; Yao et al., 2002). 
 
 Key Genetic Influences 
Gonadal sex determination is triggered by activation of the sex determining region of the Y 
chromosome (SRY). This occurs in the UGR at E10-10.5 in mice, and at approximately 6 
weeks gestation in humans (Kim & Capel, 2006). This activation is localised within the UGR 
in the Sertoli cell precursors (Bullejos & Koopman, 2001). When SRY is expressed, the 
bipotential gonad is influenced to follow a testis-specific genetic cascade, becoming 
morphologically distinguishable from female gonads by E13 (Kim & Capel, 2006; Staack et 
al., 2003). In mice, SRY must act within a small developmental window, as it is only transiently 
expressed in the Sertoli cell precursors. This differs from human expression where SRY is 
constitutively expressed in the Sertoli cells from sex determination through to adulthood 
(Sinclair et al., 1990). When SRY expression in the male is impaired or insufficient, the 
developmental pathway of the testes is heavily impacted, as is the downstream development of 
secondary male sex characteristics and reproductive structures (Goodfellow & Lovell-Badge, 
1993). For example, in the presence of SRY, Sertoli cells begin to express anti-Mullerian 
hormone (AMH), inducing regression of Mullerian ducts which would normally progress into 
female reproductive organs (Cool et al., 2012). 
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Following the expression of SRY, the target gene SRY-box transcription factor 9 (Sox9) is 
upregulated in Sertoli cell precursors. Sox9 in turn upregulates other genes such as desert 
hedgehog (Dhh) which acts to promote further differentiation of the interstitial cells (Bitgood 
& Mcmahon, 1995; Jeske et al., 1995; Kashimada & Koopman, 2010; Park et al., 2011). 
 
Dhh drives the formation of the peritubular myoid cells (PTMCs), the formation of the physical 
barrier between interstitium and seminiferous tubule, and LC differentiation (Clark et al., 2000; 
O’Hara & Smith, 2015; Yao et al., 2002). Dhh knockout mouse models demonstrate the 
reduction in proliferation and development of both PTMCs and androgen producing Leydig 
cells (LCs). Similarly, human mutations in DHH result in an XY sex reversal. This illustrates 
the sensitivity of the complex genetic developmental network and the importance of correctly 
functioning gonads in reproductive development (O’Hara & Smith, 2015). 
 
SOX9 maintains its own expression by activating fibroblast growth factor 9 (Fgf9) (Lai et al., 
2016). This interaction between Fgf9 and Sox9 is therefore essential for ensuring proper 
function and development of the testis (Arango et al., 1999; Modi et al., 2006). 
 
Table 1: The function of key genes of early male gonadal pathway development 
Gene Function in Embryogenesis  Function in Testis Development 
SRY Triggers the testis developmental 
cascade (Sinclair et al., 1990). 
Presence of SRY enables 
differentiation of Sertoli cells from 
precursors, overriding the ovary 
granulosa cell fate (Kashimada & 
Koopman, 2010). 
Sox9  Sox9 is expressed in sites of 
chondrogenesis, central nervous 
system, and other tissues including the 
genital ridge. It is required to initiate 
AMH transcription (Cameron & 
Sinclair, 1997; Kent et al., 1996; 
Wright et al., 1995). 
Expression in Sertoli cells promotes 
the male developmental pathway 
through repression of the ovarian 
pathway. (Arango et al., 1999; 
Chaboissier et al., 2004; Kent et al., 
1996) 
Sf1  Contributes to formation of 
steroidogenic gonad and adrenal 
tissues, also expressed in pituitary and 
hypothalamus (Ikeda et al., 1994) 
Essential for the maturation, 
development of Sertoli cells, and 
spermatogenesis (Kato et al., 2012). 
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Gene Function in Embryogenesis  Function in Testis Development 
AMH Factor causing the regression of 
Mullerian ducts in males (XY), 
preventing female (XX) development, 
and enabling growth of functional 
testicular tissue (Josso et al., 1993; Lee 
et al., 1996).  
Expression in Sertoli cells required 
for development of both Sertoli cells 
and LCs, needed for 
spermatogenesis (Lee et al., 1996; 
Munsterberg & Lovell-Badge, 1991; 
Racine et al., 1998). 
Fgf9 Critical for mesenchymal proliferation, 
regulates the Wnt signaling pathway in 
epithelium, involved in patterning of 
embryonic axis (Del Moral et al., 2006; 
Geske et al., 2008). 
Enables the development and 
proliferation of PTMCs, maintains 
Sox9 expression thus contributing to 
sex determination. Upregulates male 
germ cell related markers (Bowles et 
al., 2010; Park et al., 2011). 
Lhx9 Activation of Sf1 and regulation of 
neural tissue differentiation and limb 
patterning (Rétaux et al., 1999; 
Wilhelm & Englert, 2002). KO mouse 
model shows complete lack of gonadal 
proliferation (Birk et al., 2000). 
Involved in gonadogenesis and 
expressed later in LCs (Mazaud et 
al., 2002; Rétaux et al., 1999).  
Nestin Neural stem cell and proliferating cell 
marker (Jiang et al., 2014). 
Marker of SLCs (Davidoff et al., 
2004; Jiang et al., 2014).  
Notch Essential for the morphogenesis of 
vasculature, liver development, and 
impacts cell ability to react to 
instruction thus cell fate (Krebs et al., 
2000; Weinmaster, 1997; Zong et al., 
2009). 
Involved in maintaining a LPC state; 
plays a role in spermatogenesis 
(Hasegawa et al., 2012; Murta et al., 
2013) 
Dhh Required for mammalian 
spermatogenesis, earlies indicator of 
male sex determination (Bitgood et al., 
1996).  
Drives PTMC and LC development. 
Contributes to the formation of the 
barrier between the interstitium and 
the seminiferous tubules (Clark et 
al., 2000; O’Hara & Smith, 2015) 
 
1.3. Leydig Cells 
As the primary androgen source, the correct development of LCs is imperative to the 
functionality of the male reproductive system. Testosterone is vital to many biological 
processes. In the reproductive process of spermatogenesis alone, there are a multitude of events 
which are reliant on testosterone. These include the formation of the seminiferous tubule 
lumen, maintenance of both spermatogonia population and the blood-testis barrier, 
spermatocyte meiosis completion, and release of mature sperm (Huhtaniemi & Pelliniemi, 
1992).  
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 Development and Function from Embryo to Adult 
Foetal Leydig cells (FLCs) and adult Leydig cells (ALCs) are the two key Leydig populations 
(Mendis-Handagama & Ariyaratne, 2001). The two populations differ in not only morphology, 
but also differ functionally with regards to types and volumes of testosterone produced to 
support spermatogenesis and the developmental needs at that point in time (Ge et al., 2006; 
Inoue et al., 2016). Both populations arise from a stem LC population which is marked by 
Nestin (Davidoff et al., 2004; Ge et al., 2006). 
 
FLCs appear flat and oval, and contain many lipid droplets, whereas ALCs appear larger and 
more dense. FLCs develop prenatally and produce androstenedione, an androgen crucial for 
the differentiation of male genitalia (Habert et al., 2001). Androstenedione is converted into 
testosterone within Sertoli cells through 17β- Hydroxysteroid dehydrogenase 1 (HSD171) 
activity. HSD17 acts through catalysing the conversion between a precursor of androgens to 
testosterone and estradiol, achieved through oxidation of the carbon 17 position in the pre-
converted steroids (He et al., 2016; Huhtaniemi & Pelliniemi, 1992; Kraft et al., 2005). 
 
ALCs are found in the developed testes and produce higher amounts of testosterone which 
functions to drive spermatogenesis (Benton et al., 1995). Other cellular characteristics noted in 
Figure 1 illustrate the three stage developmental model which ALCs go through to reach a 
mature state. The chronological development to reach a mature ALC progresses through 
Leydig progenitor cell (LPC), immature LC, and finally ALC (Yao et al., 2002). FLCs 
comparatively do not go through as many developmental stages, as they differentiate directly 
from the LPC, they have low mitotic activity as a result of directly developing from the stem 
cell population (Hobert & Westphal, 2000). 
 
There are several points of controversy as to the origin of the foetal and adult Leydig cells. It 
has been hypothesised by some that they develop from the same progenitor cell, and by others 
that they differentiate from different progenitor cell populations (Barsoum et al., 2020; DeFalco 
et al., 2011). A third theory discovered through lineage tracing experiments suggests the 










Figure 1 – Cellular characteristics and chronological evolution of LPCs to ALCs.  
The chronological cellular and morphological development between LPC and matured ALC. 
Differences in testosterone-related cellular characteristics between the developmental stages are listed. 
Abbreviations: LC = Leydig cell, LPC = Leydig progenitor cell, ALC = adult Leydig cell. Adapted from 
(Chen et al., 2009). Created with BioRender.com. 
 
Understanding the timeline of reproductive system development is critical to gaining insight 
into any abnormalities that may arise in the adult. More specifically, understanding 
mechanisms of the primary steroidogenic cells allows for interpretation of malfunction in the 
male reproductive system as they drive a majority of the sexual dimorphism.  
 
 Role in Infertility and Loss of Function Phenotypes 
The World Health Organisation defines infertility as the inability of a sexually active couple to 
conceive a pregnancy in one year, given they are not on contraception (Vander Borght & Wyns, 
2018). The impacts of infertility and disorders of sex development (DSDs) can extend beyond 
physical experiences. Emotionally, issues begin to fester leading to mental stresses. This is 
further accentuated in the social traditionalism of bearing your own biological children (Greil 
et al., 2010). Though the reason behind many cases of infertility are undefined, the ones which 
are understood have a genetic basis which contributes to the complexity of the disease (Ferlin 
et al., 2007). 
Cellular Characteristic Progenitor LC Immature LC Adult LC 
Mitotic Activity High Divides once Likely none 
Morphology Spindle shape Round containing large 
lipid droplets 
Round containing 
small lipid droplets 
Testosterone metabolism High Highest Low 
Testosterone synthesis Low Intermediate High 
Age where cell is present 21 days 35 days 90 days 
Androgen receptor High High  Low 
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The effects of atypical development and function of the reproductive system, namely the LCs 
can seem small physically, but play a large role in development of secondary sex characteristics 
and consequently, fertility. The dysfunction of LCs can be categorised as a DSD (Rey & 
Grinspon, 2011).  
 
DSDs are a broad variety of conditions which mainly present at birth/adolescence and affect 
either process of sex determination or sex differentiation (Ahmed et al., 2011; Biason-Lauber, 
2010). DSDs can be further broken down into two general categories, dysgenic and non- 
dysgenic DSDs.  
 
Dysgenic DSDs are conditions with defects in the process of differentiation of the testis in 
embryonic development. These can be perpetuated through generations, leading to early onset 
hypogonadism. In dysgenic DSDs, the function of the whole testicular system is compromised.  
 
Comparatively, non-dysgenic DSDs involve early onset of hypogonadism which can be 
syndromic, a result of malfunction in the steroidogenic cells such as Leydig or Sertoli cells, or 
general male hormone organ defects (Ahmed et al., 2011; Warne & Hewitt, 2009; White et al., 
2011).  
 
A dysfunction of LCs specifically has the potential to lead to a range of male reproductive 
illnesses, these include, but are not limited to primary hypogonadism, cryptorchidism 
(undescended testicle), and hypospadias (misplacement of urethra in male genitalia). 
Hypogonadism affects approximately 38% of men in the US (Mulligan et al., 2008), being one 
of the DSDs to affect a large range of individuals.  
 
Hypogonadism is the decrease in functionality of the gonads, thus leading to a decrease in 
production in hormones. Male hypogonadism is characterised by a reduction in testosterone 
levels as a result of abnormalities in the testes, hypothalamus, or pituitary gland (Kumar et al., 
2010; Mulligan et al., 2008). This deficiency in testosterone results in a failure to produce 
expected amounts of sperm, absence of secondary sex characteristics, infertility, and can 
impact cognitive function and development (Kumar et al., 2010). There is little known about 
the link between the development of LPCs and male infertility.  
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 Regeneration of Leydig cells  
Figure 2 illustrates how LCs regenerate through differentiating from the Nestin-positive 
LPC/stem cell population to the ALCs (Kumar & DeFalco, 2018). The stem cells/Leydig 
progenitor cells (LPCs) are capable of differentiating into a number of different cell types, 
these include adipocytes, peritubular myoid cells, and smooth muscle cells. These cells are all 
present in the testes (Chen et al., 2019, 2020; Curley et al., 2019). 
Additional LPC markers include Notch and Neurofilament heavy peptide (NF-H) (Davidoff et 
al., 2009). 
 
LCs can be directly eliminated through a LC-specific toxicant ethane dimethanesulfonate 
(EDS). EDS is administered through an intraperitoneal injection, once administered (day 0), 
the LCs will begin to die and start regeneration at approximately day 4 post injection. It is 
expected they will be near fully regenerated at day 14 (Davidoff et al., 2004; Teerds & Rijntjes, 
2007). Most EDS regeneration studies have been conducted in rats, recent studies have shown 
that treatment with EDS also causes partial loss of LCs in mice and subsequent regeneration 
(Jiang et al., 2014; Yang et al., 2017). 
Figure 2 – Schematic of potential pericyte differentiation and differentiation process from LPC to 
ALC. 
 Pericytes are believed to be the source of stem Leydig cells/Leydig progenitor cells (LPCs). Pericytes 
express Nestin, Notch, and NF-H, and are able to differentiate into four main cell types, all of which 
can be found in the testis. Pericytes differentiate into ALCs through an intermediate immature LC 
stage, where further expression of steroidogenic enzymes 3HSD and P450scc/c17 enables maturation 
into ALCs. Abbreviations: LPC = Leydig progenitor cell, ALC = adult Leydig cell, NF-H = 
Neurofilament heavy peptide. (MJ. Wilson, Original work 2020). 
 9 
Based off this knowledge about the differentiative process of LPCs to ALCs, and the LC-
specific toxicant which enables specific elimination of LCs, we can create a model for studying 
different aspects of LC regeneration in vivo. 
 
1.4. The Lhx9 gene 
Our research focuses on the role of the Lhx9 gene in embryonic and adult reproductive 
development. Lhx9 belongs to the LIM Homeobox domain transcription factor family. The 
LHX9 protein is a transcription factor which is associated with many processes in 
embryogenesis. These include the regulation of cell proliferation in the central nervous system 
and hindlimb, development of the pineal gland, and retinal growth (Atkinson-Leadbeater et al., 
2009; Bertuzzi et al., 1999; Rétaux et al., 1999; Yamazaki et al., 2015). Despite these extensive 
developmental roles, research conducted by Birk et al (2000) showed Lhx9 to only be essential 
in the process of gonadogenesis. Through using an Lhx9 knockout (Lhx9-/-) mouse, it was 
observed that development in the limbs and central nervous system progressed normally, where 
the only notable defect found was gonadal agenesis. This suggested a functional redundancy 
in the limb/CNS function, likely accredited to gene Lhx2, the closest genetic relative to Lhx9 
(Ottolenghi et al., 2001; Rétaux et al., 1999). 
 
Lhx9 is conserved across a number of species for similar functions such pallial development in 
tetrapods, and retinal growth in Xenopus laevis and chicken species, there is also a murine 
orthologue. Reproductively, orthologues can be found in species such as chicken (Gallus gallus 
domesticus), the American cockerspaniel, and zebrafish (Danio rerio) (Atkinson-Leadbeater 
et al., 2009; Mazaud et al., 2002; Moreno et al., 2004; Pujar et al., 2005). The research which 
has contributed to the knowledge of the Lhx9 across several species is indicative of the 
importance of the role it plays in reproductive development, the high level of conservation 
highlights incentive to investigate it in humans. 
 
 Proposed Role of Lhx9 in Leydig cells 
The experimental data using in situ hybridisation by Mazaud et al (2002) shows the expression 
of Lhx9 is present in undifferentiated gonads. The AMH-positive epithelial cells of the 
undifferentiated gonads progress into Sertoli cells within the seminiferous tubules (Mazaud et 
al., 2002). Comparatively, Lhx9-positive cells are maintained in the interstitial mesothelial cells 
of the differentiated testes, these develop into LCs (Schmahl et al., 2000).  
 10 
Postnatally, Lhx9 expression progressively decreases to become near undetectable in rat and 
chick testis as the majority of the LC differentiation is completed. The expression of Lhx9 in 
the reproductive system is restricted to the suggested LPCs (DeFalco et al., 2011). This 
illustrates the inverse relationship between the expression of Lhx9 and the differentiation of 
cells in the gonads (Hamada et al., 1999). It can therefore be hypothesised that a reduced 
expression of Lhx9 will result in a reduced pool of LPCs.  
 
As a contributor to a complex network of interactions, it is likely there are a number of factors 
which may lead to regulation of Lhx9. An important regulatory factor of Lhx9 is the 
transmembrane receptor Notch (Tang et al., 2008). Notch signalling is involved with the 
differentiation and maintenance of the LPC pool. The expression of Notch and downstream 
gene targets, coincides with the development and differentiation of embryonic gonad somatic 
cells (Tang et al., 2008). Expression of Lhx9 also increases in the presence of Notch signalling 
inhibitors (Mazaud et al., 2002). This provides supporting evidence to the data reviewed by 
Martin, L. (2016), exhibiting an increase in LC differentiation in XY gonads fostered from an 
inhibition of Notch signalling (Martin, 2016).  
 
Correlating with the reviewed data, the constitutive signalling of Notch leads to a decrease in 
LC population suggesting Notch is responsible for maintaining the LPC population, and 
prevents differentiation into the mature ALC pathway. Existing LCs and Sertoli cell 
populations are not impacted by alterations in Notch signalling patterns (Tang et al., 2008). 
From these observations made, Notch appears to have a “stabilising” effect on the progenitor 
cell state by demoting differentiation into LCs. When absent, the cells begin to commit down 
LC line fate. A decrease in Notch therefore results in a decrease in Lhx9 and consequently a 
reduced LC population.  
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1.5. Project Overview 
Understanding the developmental processes of LCs, including their regeneration, is important 
to the study of reproductive health. Aging LCs are likely to be a source of declining fertility 
because of an age-associated net decline of the LC population, causing an overall decrease in 
testosterone. Many complex fertility issues can arise as a result of testosterone deficiencies 
such as hypogonadism and dysfunctional spermatogenesis. With the gonadal primordium as 
the main model of this project, we are able to study cell fate specification, this could potentially 
aid in stem cell therapy development and research to contribute to possible fertility treatments.  
 
To understand the full developmental processes which take place in the embryonic testes, the 
development of steroidogenic LCs must be understood. This project will explore the effects of 
Lhx9 on the LPC pool, and consequently how this impacts the differentiation into foetal/adult 
LCs using heterozygous mice (HET = Lhx9+/-). Previously, the Wilson Laboratory had shown 
that these mice produced reduced levels (50%) of Lhx9 during gonadal development (Workman 
& Wilson, unpublished).  
 
This project tested this through two hypothesis and a number of different objectives. 
 
Hypotheses: 
1. Reduced Lhx9 results in earlier differentiation of progenitor cells to foetal Leydig cells. 
This also would also decrease the size of the progenitor pool. 
 
2. Reduced expression of Lhx9 will lead to a decrease in progenitor cells and an increase 
in adult Leydig cells. This will consequently result in a premature loss of Leydig cells 
in the adult testis. 
 
Objectives:  
1. To observe Lhx9 expression over time. 
- RT-qPCR analysis of a number of marker genes at the following timepoints of 
development compared to Lhx9 mRNA expression: E15.5, P0, P20, adult (3-5 
months old). 
- Immunohistochemistry to observe the target gene protein levels in adult testis. 
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2. To monitor changes to gene expression upon reduced Lhx9 expression.  
- RNA sequencing of 4 month old WT and Lhx9+/- testes RNA to observe changes 
in gene expression. 
- RT-qPCR of E15.5 WT and Lhx9+/- testes RNA to observe changes in gene 
expression. 
 
3. To understand the effects of reduced Lhx9 on the regenerative development of Leydig 
cells. 
- Intra-peritoneal injection of LC specific toxicant ethane dimethanesulfonate 
(EDS) administered to mice to eliminate LCs.  
- RT-qPCR for marker gene expression in testes at different key timepoints in LC 




2. Methods  
2.1. Animal Husbandry 
C57BL/6 and Lhx9+/- mice were sourced from the Jackson Laboratory (Bar Harbor, Maine, 
USA) and maintained at the Hercus Taieri Resource Unit (HTRU) and housed in cages fitted 
with ad libitum water and food access. The cages were stored in the Animal House where the 
facility operated on 12-hr light/dark cycles. 
 
The Lhx9+/- mouse strain was re-derived from backcrossing frozen sperm and a DBA2J 
background by the Jackson Laboratories (https://www.jax.org/strain/006812), at Otago it has 
been backcrossed onto a C57BL/6 background. The line was originally constructed by Birk et 
al (Birk et al., 2000) deleting exons 2 and 3 of the Lhx9 gene by insertion of a neomycin 
cassette.  
 
To breed, one male and one female were housed together before the start of the dark cycle. 
Females were checked the following morning for a copulatory plug indicative of successful 
copulation (Deb et al., 2006). The time of copulatory plug detection was recorded as 0.5 days 
post coitum (dpc). The dam was then placed into a separate cage from the sire. When there was 
an absence of copulatory plug, mating continued until a copulatory plug was observed or until 
the mating reached four days. If no plug was observed after four days, the mice were separated 
and the females monitored for signs of pregnancy in case of a missed plug.  
 
Protocols performed all had approval from the University of Otago Animal Ethics Committee.  
 
2.2. Genotyping 
 DNA Isolation  
DNA was isolated from embryo tail tips or adult ear notch samples. Each tube containing a 
single sample had a mix of 150 µL lysis buffer, and 1 µL proteinase K. The tubes were 
incubated in a heat block at 55 °C overnight to degrade the tissue. The tubes were heated to 85 




 Polymerase Chain Reaction (PCR) 
PCR was used for the amplification of a specified region of the DNA extracted from the embryo 
tail tips and ear notches. To assess the Lhx9 genotype, primers designed to amplify the 
neomycin cassette inserted to create the knockout line were used. Reagents listed in Table 2 
were added and briefly centrifuged to ensure all components were collected at the bottom of 
the tube. The tubes were run on an genotyping programme in the Applied Biosystems Veriti 
96 well thermal cycler as listed in Table 3 
 
Table 2: Stock and concentration of Lhx9 Genotyping PCR protocol 
Reagent Concentration µL per Reaction 
Neomycin Primer - 1  
Reaction Buffer 10 x 2 
dNTPs 10 mM 0.2 
Taq 5 U/µL 0.1 
ddH2O - 13.8 
DNA - 2 
 
Table 3: Thermal profile for Lhx9 genotyping 
Cycle Temperature Time 
1 94 °C 3 min 
35 94 °C 30 s 
60 °C 1 min 
72 °C 1 min 
1 72 °C 2 min 
- 4 °C Hold 
 
 Gel Electrophoresis 
Amplified PCR products from the genotyping protocol were visualised through gel 
electrophoresis. 10 µL of each PCR product and 1 µL of 1 kb DNA Ladder were loaded into 
wells of a 2% agarose gel and submerged in 1x Tris-acetate-EDTA (TAE) buffer in a gel tank. 
The gel was left to run for approximately 30 minutes and the DNA visualised in a UVP GelDoc 
under a UV light. Samples with a band at approximately 492 base pairs indicating the presence 




2.3. Inhibitor Treatment of Male Mice 
Ethane dimethanesulfonate (EDS) is a Leydig cell specific toxicant. 250 mg stock EDS was 
dissolved in 1.7mL of vehicle solution (30% Dimethyl sulfoxide (DMSO) and 70% H2O) to 
give a 30 mg/mL working solution. A final dosage of 160mg/kg was injected.  
 
Mice were weighed to calculate the injection volume of either EDS/vehicle through the 
following equation: 
 
(𝑊𝑒𝑖𝑔ℎ𝑡 𝑖𝑛 𝑘𝑔 ×  160)
30
= mL Injected 
 
Room temperature EDS/vehicle was drawn into 1mL syringes with needles gauge size 25-27. 
Mice were restrained via the scruff technique and tilted at an angle where the head was lower 
than the body allowing organs to fall away from the injection site. The needle was inserted 
bevel up into the lower right quadrant of the mouse and an aspiration was performed before 
the solution was injected intraperitoneally. Each mouse was monitored daily for any negative 
body weight, behavioural, or overall health changes.  
 
Figure 3 – Example Lhx9 genotyping results via gel electrophoresis.  
The presence of bands in lanes 2, 3, 4, 7, and 8 at the 492 bp mark indicate the presence of the neomycin 
cassette and therefore heterozygosity in Lhx9. The lack of band in the negative control (-ve) lane 
ensures confidence the results are not due to experimental error. ddH2O used as negative control.  
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2.4. Tissue Collection 
Adult mice were euthanised at days zero, four, or fourteen post EDS injection through cervical 
dislocation. The abdomen of the mice were opened after being sprayed with 70% ethanol. 
Blood samples were drawn via cardiac puncture and left to rest for serum collection for a 
minimum of 30 minutes. The seminal vesicles were also dissected out for weight 
measurements. The adult testes were removed and immediately placed into 4% PFA for 
fixation, or in RNALater (Sigma Aldrich, USA) for RNA extraction. 
 
Adult mice were euthanised for embryo collection eighteen days after plug observation to 
collect E18.5 embryos. Embryos were immediately placed in a sterile petri dish with PBS after 
being removed from the mother followed by decapitation. The embryos were dissected under 
the dissecting microscope after being removed from the extra-embryonic membranes. The 
embryo tail tips were removed for necessary genotyping to determine either the sex or the Lhx9 
genotype of the embryo (see 2.2.1). Gonads were removed and placed immediately into 
RNALater. WT embryos and heterozygous embryos were collected from the same litter.   
 
 Serum Collection 
Blood drawn via cardiac puncture was left to rest at room temperature to allow for blood to 
coagulate for 30 mins to 1 hr. Blood was centrifuged at 3500 g for 10 mins at 4 °C to allow the 
separation of the serum (top layer) from the red blood cells (bottom layer). The serum was 
carefully collected without disturbance of the red blood cells into a new tube before storing at 
-20 °C. 
 
2.5. RNA Extraction 
Two methods of RNA extraction were used depending on the size of the tissue sample.  Smaller 
tissue such as embryonic testes were extracted through the Bioline Isolate II RNA Mini Kit, 
where a Trizol-based protocol was used for larger adult testis samples.  
 
 RNA Extraction: Smaller Tissues 
The Bioline Isolate II RNA Mini Kit was used for RNA extraction from embryonic testes. 
Tissue was homogenised using a pestle in 350 µL of the supplied Lysis Buffer RLY. RNA 
extraction and purification was carried out according to the protocol provided by the 
manufacturer. The RNA was eluted into 60 µL of RNase-free water.  
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 RNA Extraction: Larger Tissues 
The RNA extraction from the adult testes was completed using a Trizol-based method. 500 µL 
of Trizol was added into a glass homogeniser containing the tissue. The tissue was ground until 
homogenous, followed by the addition of another 500 µL of Trizol which was incubated at 
room temperature for 5 minutes to allow for the dissociation of the cells. 200 µL of chloroform 
was then added and the sample was shaken vigorously for 15 s followed by a 3 min rest period 
at room temperature. Following the rest period, the samples were then centrifuged at 15,000 g 
for 15 min at 4 °C to enable the separation of the sample into three layers; a top clear aqueous 
layer of RNA, a middle white layer of DNA, and a bottom pink layer of organic proteins. The 
top aqueous layer was removed carefully without disturbing the other layers and pipetted into 
a new sample tube containing 500 µL of isopropanol. The sample was then vortexed and rested 
for 10 min at room temperature before being centrifuged at 12,000 g for 10 min at 4 °C. 
Following centrifugation, the supernatant was removed and the remaining pellet resuspended 
in 1 mL of 100% ethanol by brief vortexing. The sample was centrifuged at 7,500 g for 5 min 
at 4 °C. The supernatant was removed following the centrifuge and the pellet left to dry for 30 
min to 1 hr.  
 
The pellet was then resuspended in 50 µL of RNase-free water and incubated on a heat block 
for 10 min at 57.5 °C before storage at -20 °C.  
 
2.6. cDNA Synthesis 
Complimentary DNA (cDNA) was synthesised using qScript cDNA SuperMix (5x reaction 
buffer) from QuantaBio. The reaction set up was as follows: qScript (4 µL), RNA template 
(calculated by 200/nanodrop concentration), and RNase-free H2O (variable amount to make 
reaction volume to 20 µL) was added. cDNA synthesis was completed using the Applied 
Biosystems Veriti 96 well thermal cycler with the following programme: 25 °C (5 min), 42 °C 
(60 min), 85 °C (5 min), and 4°C (hold). 
 
2.7. Real-Time Quantitative PCR 
The relative expression of genes in the testes samples were quantified through real-time 
quantitative PCR (RT-qPCR). The cycles were normalised against two reference genes, 
ribosomal protein S29 (Rps29) and actin beta (Actb).  
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 Primer Design & Efficiency Analysis 
Primers were designed through Primer BLAST after sourcing the gene mRNA transcripts from 
NCBI. Primer BLAST parameters altered from the default setting were set to the following: 
100-120 bp PCR Product size, exon junction span to span an exon-exon junction, and organism 
set to Homo sapiens (taxid: 9606). 
 
Primer sequences can be found in Appendix 2. The efficiencies of the primers were tested in a 
5-fold serial dilution of cDNA in RT-qPCR master mix The plate was sealed off with a plastic 
sheet and contents were centrifuged down at 2000 g for 15 s.  
 
The Applied Biosystems QuantStudio3 Real-Time PCR Systems machine was used to run the 
thermal profile outlined in Table 4. A non-linear regression plot was generated in PRISM 
(Appendix 3) based on the Ct values calculated for each replicate, determining the slope which 




(− 1𝑠𝑙𝑜𝑝𝑒)−1) ×  100 
 
 
Primers with efficiencies between 85-120% were of deemed suitable for use in RT-qPCR 
experiments. 
 
 Reaction Set up 
The reactions for RT-qPCR were set up in a 96-well plate. Each well contained 1 µL of sample 
cDNA, and 9 µL of RT-qPCR reaction master mix. The master mix was made up of 5 µL of 
SYBR Green Fast Mix, 3 µL of RNase-free H2O, and 1 µL of primer (forward and reverse). 
Each test sample was carried out in triplicate to act as technical replicates. The plate was sealed 
off with a plastic sheet and contents were centrifuged down at 2000 g for 15 s.  
 
The Applied Biosystems QuantStudio3 Real-Time PCR Systems machine was used to run the 
thermal profile outlined in Table 4 
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Table 4: Thermal profile for RT-qPCR reaction. 
Temperature  Time Cycles 
55 °C 2 min 1 
95 °C 2 min 40 
95 °C 5 sec 
60 °C 19 sec 1 
Machine specific melt curve programme 
 
 
 Data Analysis 
The melt curve was analysed for a single peak in each sample to ensure specificity of 
amplification of a single product (Appendix 4), deeming the data suitable for relative gene 
expression analysis. The mean Ct value of three technical replicates were compared to the mean 
Ct value of two reference genes Rps29 and Actb,  with the relative expression being calculated 
as shown. 
 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 = 2− (𝑚𝑒𝑎𝑛 𝐶𝑡 𝑔𝑒𝑛𝑒 − 𝑚𝑒𝑎𝑛 𝐶𝑡 𝑟𝑒𝑓 𝑔𝑒𝑛𝑒) 
 
2.8. Histology 
Tissue was fixed in 4% PFA overnight and washed in PBS to be embedded by the Otago 
Histology Services Unit in paraffin wax. Tissues were sectioned at 5 µm on a microtome and 
placed onto slides to dry and set at 60 °C for 60 min. Sections to be used for histological analysis 
were stained in the Otago Histology Services Unit in haematoxylin and eosin (H&E) using a 
standard protocol (Fischer et al., 2008).  
 
2.9. Immunohistochemistry 
Sectioned 5 µm tissue samples prepared using a microtome were used for 
immunohistochemistry. 
 
 Antigen Retrieval 
Sections were deparaffinised and rehydrated with a series of washes as follows: 2x 100% 
xylene for 3 mins, then ethanol/H2O dilutions (100% x2, 90% x1, and 50% x1) for 3 min each. 
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Slides were then placed into a plastic slide holder and covered in sodium citrate buffer in a 
vented microwaveable container. The container was microwaved at medium-power for 30 min, 
adding buffer when necessary to ensure there was enough to prevent the slides from drying 
out. Container was cooled at room temperature for 15 min before rinsing the slides in RNase-
free water.  
 
 Primary Antibody Binding 
Slides were washed in PBS with 0.025% Triton-X (PBTx) three times for 10 min each. They 
were then blocked in PBTx + 10% heat inactivated sheep serum + 1% bovine serum albumin 
solution for 2 hr at room temperature. The slides were then incubated overnight at 4 °C in a 
wash with primary antibodies diluted in the blocking solution. Slides were also incubated with 
a solution containing no antibody as a control.  
 
Table 5: Immunohistochemistry Antibody Dilutions 
Target Primary antibody Dilution Secondary antibody Dilution 
LHX9 
Generated by the 
Wilson lab (Y Yang, 
2018). 
1 in 2000 
Goat Anti-Rabbit 
IgG H&L (HRP) 
ab205718 





1 in 25 
Goat anti-mouse 
(HRP) 
1 in 600 
 
 
 Secondary Antibody Binding & Colour Development 
To remove any unbound antibodies, slides were washed in PBTx three times (5 min per wash) 
at room temperature, then incubated with 3% H2O2 for 5 min to inhibit any endogenous 
horseradish peroxidase (HRP) activity. Following the incubation, blocking solution was added 
and slides were blocked again for 20 min.  
The secondary antibody/blocking solution dilution was then added to the slides for 20 min at 
room temperature. Unbound secondary antibodies were washed off with three 5 min washes in 
PBTx. 
 
DAB substrate kit (Abcam - ab64238) was used to develop the colour according to 
manufacturer instructions. Sections were then counterstained in 50% Haematoxylin for 10 s.  
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2.10. RNA Sequencing 
The RNA was isolated (see 2.5) and quality check was performed via nanodrop. The RNA was 
dried down and treated with RNA Stable before being sent to Beijing Genomics Institute (BGI), 
Hong Kong, for sequencing and RNA integrity number (RIN). 
The genomic library was prepared by BGI using their own sequencing platform – DNBseq. 
100bp paired end reads were sequenced and returned. 
The clean paired end reads were mapped and analysed via the following Galaxy software tools: 
 
- Feature counts: galaxy version 1.6.4+galaxy1 – tool version v1.6.4 
- MultiQC: galaxy version 1.8+galaxy0 
- HISAT2 Software: 2.1.0+galaxy5 
- FastQC: 0.72+galaxy1 
- BAM to BigWig conversion: 1.0.2 
 
Differential gene expression analysis was done by Dr Megan Wilson using RUVSeq/DESeq2 
R packages, genes differentially expressed with a FDR of 0.1 were considered further (due to 
the low sample number). 
 
Gene ontology analysis was done using DAVID (Version 6.8), and Panther (Version 15.0) 
using default settings.  
 
2.11. Statistical Analysis 
Statistical analyses was carried out using either an unpaired t-test or a one-way ANOVA with 




3.1. Lhx9 mRNA Expression during Leydig cell Differentiation 
 Selection of Target Genes 
A series of target genes to be used for expression analysis were chosen based on their role in 
the development and function of LCs.  Markers of Leydig progenitor cells (LPCs) used were 
Nestin, Notch, Patched-1(Ptc1), and Aristaless (Arx). Mature LC markers used include 
cholesterol side-chain cleavage enzyme (P450scc), cytochrome P450 17A1 (P450c17), 3- 
hydroxysteroid dehydrogenase (3HSD), platelet derived growth factor receptor subunit-A 
(Pdgfra), leukemia inhibitory factor receptor (Lifr), and vascular cell adhesion molecule 
(Vcam). RT-qPCR assays are shown relative to the expression of reference genes ribosomal 
protein S29 (Rps29), and actin beta (Actb). Together, these sets of markers can provide insight 
into the proportion of LPCs and ALCs in the Lhx9+/- (HET) testes and whether that proportion 
is altered in comparison to Lhx9+/+ (WT) littermates. This can begin to build evidence as to 
what the role of Lhx9 may be during embryogenesis and LC function. A selection of these 
genes were also used to generate a timeline of their expression over the perinatal (E15.5 – P4) 
and the adult period, giving insight into how the markers are expected to change during this 
time and what the implications of change in a Lhx9+/- may be beyond E15.5. The specific 
function of the genes used in RT-qPCR is listed in Table 6 below. 
 
Table 6: Target genes and their function in Leydig cells 
Target gene Function in LCs 
Nestin Marker of LPC (Davidoff et al., 2004). 
Notch Maintains the progenitor state of the LPCs, expression prevents differentiation into 
mature LCs (Tang et al., 2008). 
Arx Functions to promote the differentiation of FLCs through paracrine signaling (Yu 
et al., 2014). 
3HSD Marker of differentiated progenitor cells, involved with steroidogenesis 
(Rasmussen et al., 2013; Teerds et al., 2007). 
Patched-1 Triggers LC differentiation through upregulation of P450scc (Yao et al., 2002). 
P450scc Catalyses cholesterol to steroid hormone synthesis (Wang et al., 2017). 
P450c17 Contributes to steroid synthesis pathway (Chung et al., 1987). 
Pdgfra Receptor found on ALC surface for PDGF, responsible for LC differentiation 
(Basciani et al., 2010). 
Lifr Marker of stem cell proliferation and differentiation (Curley et al., 2018). 
Vcam Adhesion promoting molecule expressed in ALC (O’Shaughnessy et al., 2002). 
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 Primer Design Efficiencies 
Forward and reverse primers were either sourced or designed for each marker gene using NCBI 
Primer BLAST and tested for efficiency as outlined in 2.7.1. Each reaction produced a melt 
curve which was analysed to ensure the amplification of a single product (see example in Figure 















RT-qPCR primer efficiencies were run in serial dilutions (2.7.2). Primer efficiencies are listed 
below (Table 7). 
 
Table 7: Target gene primer efficiencies 
Gene target Efficiency Gene Efficiency 
3HSD 106.76% Pdgfra 87.63% 
Arx 96.99% Vcam 93.32 
Lifr 118.5% Fgf1 120% 
Nestin 114.46% Rps29 114.1% 
Notch 112.23% Actb 99.5% 
P450c17 107.28% Patched-1 108.68% 
P450scc 112.91% Lhx9  109.13% 
 
A. B. 
Figure 4 – Representation of RT-qPCR efficiency measures. 
A. Efficiency curve for gene Aristaless, efficiency of 96.99% is suitable for RT-qPCR.  
B. Melt curve displaying the changes of fluorescence relative to temperature, where a single peak 
indicates amplification of a single product and suitability for downstream analysis. Melt curves for full 
list of genes can be found in Appendix 4.  
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 Leydig cell Marker Gene Expression changes in the Perinatal Period 
The relative expression of the LC marker genes of interest were calculated as outlined in 2.7.3, 
using the RNA extracted from the testes. The expression of the genes was normalized against 
two reference genes, Rps29 and Actb. Timelines were created for a total of 6 marker genes 
selected to represent function and various cell types in the testes.  
 
Figure 5 shows the changes of Lhx9 in WT mice across different points of development. The 
expression of Lhx9 quantified for RT-qPCR appears to peak at birth/postnatal day 0 (P0), 
before declining at P20 and even further so at adult age (3-5 months of age). Expression was 
significantly different between P0 and adult stages (p = 0.02, one-way ANOVA with Tukey’s 
multiple comparison test). This may represent the developmental requirements of LPCs at each 
timepoint.  
 
Additionally, Figure 6 illustrates the trends of key marker genes investigated in this project 
alongside Lhx9. LPC marker Nestin (Figure 6A) appears to peak at E15.5 and declines to 
minimal relative expression in the post-natal P20 and adult testes. Expression was significantly 
different between E15.5 and P20 stages (p = 0.04, one-way ANOVA with Tukey’s multiple 
comparison test). Similarly, Notch follows a parallel expression pattern where peak levels are 
seen at E15.5 a period of peak FLCs differentiation (Chen et al., 2010) (Figure 6B).  
Figure 5 – Lhx9 expression in WT testes at varying developmental timepoints.  
For each timepoint, Lhx9 expression is shown relative to the reference genes (Actb and Rsp29). RT-
qPCR assays were carried out on biological replicates: E15.5 (n=3), P0 (n=3), P20 (n=3) and adult 
testis (n=4). Data shown is mean +/- SEM. Abbreviations: E15.5 = Embryonic day 15.5, P0 = 
Postnatal day 0, P20 = Postnatal day 20, and adult = 3-5 months of age. Statistical analysis used was 
a one-way ANOVA with Tukey’s multiple comparison test. Within each graph, labels above bars 
indicate statistical significance between the lettered data groups, data is represented as follows: A = 
E15.5, B = P0, C = P20, and D = Adult. 


























The expression was significantly different between E15.5 and each of the following timepoints, 
P0 (p = 0.009), P20 (p = 0.004), and adult (p = 0.007), all of which were calculated through 
one-way ANOVA with Tukey’s multiple comparison test.  
 
Steroidogenic enzyme markers were examined by RT-qPCR were 3HSD, P450c17, and 
P450scc (Figure 6C, D, & E). 
 
 
Figure 6 –Relative expression timeline of key testicular marker genes at varying developmental 
timepoints in WT testes . 
For each timepoint, expression of genes of interest is shown relative to the reference genes (Actin 
and Rps29). RT-qPCR assays were carried out on the following biological replicates: A. Nestin: 
E.15.5 (n=2), P0 (n=2), P20 (n=3), 4 month adult testis (n=1), B. Notch: E.15.5 (n=2), P0 (n=3), 
P20 (n=3), adult testis (n=2), C. 3HSD: E.15.5 (n=3), P0 (n=3), P20 (n=3), adult testis (n=2), D. 
P450c17: E.15.5 (n=3), P0 (n=0), P20 (n=2), adult testis (n=4), E. P450scc: E.15.5 (n=7), P0 (n=1), 
P20 (n=3), adult testis (n=3), F. Patched1: E.15.5 (n=3), P0 (n=3), P20 (n=2), adult testis (n=3). 
Abbreviations: WT = Lhx9+/+, E15.5 = Embryonic day 15.5, P0 = Postnatal day 0, P20 = Postnatal 
day 20, and adult = 3-5 months of age. Statistical analysis used was a one-way ANOVA with Tukey’s 
multiple comparison test. Within each graph, labels above bars indicate statistical significance 
between the lettered data groups, data is represented as follows: A = E15.5, B = P0, C = P20, and 
D = Adult.  
P0 
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3HSD (Figure 6C) and P450c17 (Figure 6D)  appear to increase in expression with age, likely 
indicative of the increased steroidogenesis occurring in the adult testes. Relative expression is 
lowest in the younger tissues such as in E15.5, and noticeably increases by the time the adult 
tissues are developed. Due to time restraints, there is no data for the P0 P450c17 timepoint 
therefore the exact pattern of expression cannot yet be determined.   
 
The expression calculated for steroidogenic enzyme markers displayed statistical significance, 
where 3HSD E15.5 samples has significantly lower expression than both P20 (p = 0.0053) 
and adult samples (p = 0.0044). Similarly, the 3HSD expression in P0 samples were also 
significantly lower than in P20 (p = 0.027) and adult samples (p = 0.018).  
 
For P450c17, a significant increase in expression is shown in adult samples from E15.5 (p = 
0.02). Expression of P450scc (Figure 6E) was found to be significantly increased in the adults 
compared to all other samples of E15.5 (p = 0.0009), P0 (p = 0.0053), and P20 (p = 0.0008), 
the pattern of expression declines at birth before increasing from P0 onwards.  
 
 
3.2. Leydig cell Marker Gene Expression in E15.5 Lhx9+/-  Testis 
As Lhx9 is likely to have an important role in the development of LCs, the LC differentiation 
between WT and HET mice was examined between the adult and embryonic stage tissues 
through closer observation of LC marker expression. The expression levels of 11 selected 
marker genes were quantified and calculated through RT-qPCR as outlined in 2.7.3. These 
genes represented a variation of cell types and process which may be expected to occur 
differently between WT and HET E15.5 samples. Gene expression was normalized against two 
reference genes Rps29 and Actb. All statistics were calculated through an unpaired t-test.  
 
Usually acting to keep LPCs stable in the progenitor state (Barsoum & Yao, 2010), Notch 
expression was significantly reduced in the HET testis compared to WT littermates by a -4.3 
fold change (p = 0.0189) (Figure 7A). Similarly, LPC marker Nestin, displayed a reduced 
expression in the HET compared to the WT (-1.8 fold-change) although this was not 
significant, (p = 0.08) (Figure 7B). This may be representative of a small sample size.  
The reduced expression in the progenitor marker Notch in HET samples (Figure 7) imply a 






Figure 7 – Relative gene expression of different LPC marker genes between WT and HET E15.5 
testes.  
All gene expression was relative to reference genes Rps29 and Actb. RT-qPCR assays were carried out 
with the following biological replicates A. Notch: WT (n=2), HET (n=3), B. Nestin: WT (n=2), HET 
(n=3). Statistical significance determined by unpaired t-test * p <0.05. Abbreviations: WT = Lhx9+/+, 
HET = Lhx9+/-. 
Figure 8 – Relative gene expression of different steroidogenic enzyme markers in WT vs HET.  
RT-qPCR results for HET and WT E15.5 testis gene expression relative to reference genes (Rps29 and 
Act). Data shown is mean of the relative expression, error bars represent standard error of the mean.  
A. P450c17: WT (n=3), HET (n=2), B. 3bHSD: WT (n=2), HET (n=3), C.P450scc: WT (n=6), HET 
(n=2). Statistical significance determined by unpaired t-test, * p <0.05, *** p<0.001. HET = Lhx9+/-. 
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Steroidogenic enzyme marker P450c17 (Figure 8A) shows a statistically significant 8.3 fold 
increase in the E15.5 HET testis compared to WT littermates (p = 0.0001). Marker of the same 
steroidogenic process 3HSD (Figure 8B) also displays a significant increase in the HET 
versus the WT samples (2.9 fold-change, p = 0.041). P450scc, a gene  upstream of 3HSD and 
P450c17 in the same steroidogenic pathway, showed an unexpected significant decrease in the 
HET compared to the WT (-2.3 fold-change, p = 0.024) (Figure 8C). This differs from the 




Figure 9 – Relative expression of LC marker genes in E15.5 WT and HET male testes.  
Mean of the relative expression compared against reference genes (Rps29 and Actb), error bars 
represent standard error of the mean. RT-qPCR assays were carried out with the following biological 
replicates: A. Vcam: WT (n=3), HET (n=3), B. Pdgfra: WT (n= 3), HET (n=3), C. Patched-1: WT 
(n=3), HET (n=2), D. Lhx9: WT (n=4), HET (n=4), E. Lifr: WT (n=2), HET (n=2), F. Aristaless: 
(n=2), HET (n=2). Statistical significance determined by unpaired t-test. Where * p <0.05. HET = 
Lhx9+/-. 
Vcam, a marker for vascular endothelium (Kong et al., 2018) showed significantly increased 
expression in the HET testes compared to WT littermates by 1-fold, (p = 0.026) (Figure 9A).  
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Cell proliferation marker Pdgfra (Odeh et al., 2014) (Figure 9B) was also significantly 
upregulated in the HET testes by 2-fold (p = 0.012) compared to the WT samples, this marker 
is essential for LC differentiation. Expression of Lifr in the HET testis increased in some HET 
samples, however this was not statistically significant (p = 0.34) or reproducible across 
biological replications (as indicated by the large error bars).  
 
Patched-1 is required for LC differentiation (Mendis-Handagama & Ariyaratne, 2001). Two 
genes Patched-1 (Figure 9C) and Lhx9 (Figure 9D) displayed no significant changes in 
expression in HET samples. An additional gene, Arx also functions to promote LC 
differentiation (Miyabayashi et al., 2013). Arx (Figure 9F) has a slightly more prominent 
decrease in HET with a 3-fold change, however, this was also insignificant. Smaller changes 
to gene expression would be difficult to detect with smaller sample sizes.   
 
 LHX9 Protein Expression in Adult Testis  
The physical arrangement of cells can be visualized in the below schematic (Figure 10), where 
the cluster of ALCs have blood vessels through it, these are important as they are thought to 
contribute to the LPC population (Davidoff et al., 2004). Pericytes (PCs) are another suggested 
stem LC alongside LPCs to the ALCs (Eliveld et al., 2020), these can be found embedded 
within the peritubular myoid cells (PTMCs) or surrounding blood vessels (Curley et al., 2019; 
Kumar & DeFalco, 2018).  
Figure 10 – Schematic of physical arrangement of cells in adult testis.  
A schematic illustrating the physical arrangement of testicular cells with relation to the ALCs. 
Suspected  progenitor cells PCs are seen embedded within the PTMC and wrapped around the 
vasculature. Abbreviations: PTMC = Peritubular myoid cell. PC = pericyte, ALC = adult Leydig cell. 
(MJ. Wilson., Original work, 2020). 
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Figure 11 visualizes the expression of LHX9 through an immunohistochemistry (IHC). The 
staining (brown precipitate) is localized in the LCs, showing the expression of LHX9 in WT 
adult testes is primarily expressed in the interstitial cells. Some fainter staining was also 
observed in the spermatogonia (SP) within the seminiferous tubules (Figure 11B), suggesting 
additional expression of LHX9 in these cells. No background staining was observed on the 
secondary (anti-rabbit-HRP) only control (data not shown), suggesting that staining observed 
is due to binding of the primary to LHX9.  
 
Adult testes from HET mice were unable to be stained through IHC due to time limitations. 
This would be done in future to create a comparison of LHX9 protein staining to WT. A 
western blot could additionally be performed to confirm whether the quantified amount of 
LHX9 protein in an adult HET is half of an adult WT. This has been proven previously in the 
embryo (Workman, unpublished). 
 
3.3. Regenerative Ability of Lhx9+/- Mice 
Due to the previously mentioned link between Lhx9, LPCs, Notch signaling and adult Leydig 
cell differentiation (Table 6), an RT-qPCR assay was done to quantify the effects of EDS 




Figure 11 – LHX9 immunohistochemistry on WT adult (4 months) testis.  
Expression of LHX9 localised in the interstitial Leydig cells (LC), outside of the seminiferous tubules 
(ST) can be visualised through brown staining. Faint spermatogonia (SP) staining can be seen. A. 10x 











The original proposal for this experiment was to collect EDS treated samples at all three 
timepoints of LC regeneration, day of injection (day 0), proliferation of LCs (day 4), and the 
near complete restoration of LCs (day 14) based on previous literature (Jiang et al., 2014; Yang 
et al., 2017). Unfortunately, as a result of time restraints, only one litter of male mice of the 
correct age was obtained. This litter was only sufficient for a pilot study. EDS (final 
concentration of 160 mg/body weight in kg) was administered via intra-peritoneal injection to 
the mice n=1 (WT), n=1 (HET) to begin the partial elimination of LCs. Following this, the 
testes, blood, seminal vesicle weight, and body weight data was collected at day 14. As 
controls, samples collected were a day 0 (no injection) and a day 14 (injected with the 
vehicle/buffer only).  
 
Using these tissues, 5 genes of interest picked based on their important roles in the testis and 
the cell types which they marked were quantified (Figure 12) relative to two reference genes, 
ribosomal protein S29 (Rps29) and actin beta (Actb). Nestin, Notch, and Lhx9 were picked as 
they are markers of LPCs, the main cell population of interest. Where P450scc and 3HSD 
were picked based on their role in steroidogenesis, the function of the cells of interest.  
 
There were differences in expression levels after the 14 days post-EDS injection. Expression 
levels for Nestin, Lhx9, and 3HSD were all highest in the EDS treated WT mice. This is to be 
expected when in contrast with HET treatment groups as the WT are expected to have a higher 
regenerative ability. Nestin and Notch are expected to be increased due to their role in localised 
co-expression in LPCs, an increase in these two markers are likely indicative of the 
proportionate increase in proliferative activity occurring in the LPCs (Chen et al., 2017; Murta 
et al., 2013). Downstream of an increase in LPCs, we can expect to see an increase in the 
number of LCs differentiated and a subsequent increase in the amount of active steroidogenesis 
occurring (Chen et al., 2019; Hu et al., 2007). This justifies the rise in P450scc and 3HSD 
expression. 
 
The expression levels for Notch, and P450scc are all similar across all three treatment groups. 
However, with the low sample size any subtle differences in gene expression between the 




Seminal vesicle (SV) weight is an effective indicator of the amount of testosterone which is 
being produced in a mouse (Eleftheriou & Lucas, 1974; Kerr et al., 1987). The SVs were 
dissected out and weighed from each mouse of the EDS (Figure 13). The SV weight was 
divided by the overall body weight of the mouse to normalize for differences in body weight. 
The graphed results show no significant difference in SV between samples but again, it must 
be acknowledged that n=1 and therefore, no significant conclusions can be drawn. Similarly, 
with results from Figure 12, subtle differences between the treatment groups can be 
acknowledged. 
Figure 12 – Relative gene expression of marker genes in day 14 preliminary EDS study treatment 
groups. 
RT-qPCR assay on mice testes is relative to reference genes (Rps29 and Actb) A. Nestin, B. Lhx9, C. 
Notch, D. 3bHSD, E. P450scc. Where WT control = Day 0, and other treatment groups (WT no EDS, 
WT + EDS, HET + EDS) are day 14. Preliminary study therefore n=1 for all treatment groups. EDS = 




This brings light to limitations of this study given the restrictive time allowance for my overall 
project. To acquire a full set of data which enables insight across all three timepoints of LC 
regeneration, it would require much more time given that 2 weeks are needed for the LCs to 
regenerate, following injection of EDS, and required the same age of mice (4-5 month old 
mice), unfortunately no mice of the correct age were ready in time. This study has potential 
based on the presented preliminary results, indicating a different response in HET mice to EDS-
induced LC regeneration.   
 
  
Figure 13 – Mean seminal vesicle weight of mice from different treatment groups.  
Error bars represent standard error of the mean. SV weight calculated by SV/Body weight to normalise 
for body weight differences between mice (n=1). Abbreviations: SV = Seminal vesicle, EDS = Ethane 
dimethanesulfonate, HET = Lhx9+/-. 
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 Marker Protein Expression in EDS Treated Testis 
Testes were dissected and sectioned for IHC and H&E staining (Figure 14). The testis in the 
WT control (vehicle only) appear as normal, where the seminiferous tubules are round and 
abundant of spermatozoa (Figure 14). The interstitium contains LCs which appear as regular 
with vasculature running between them (orange arrowhead).  
 
The panel in the WT + EDS treatment image displays distorted looking seminiferous tubules; 
the spermatozoa appear detached from each other where there are many crack-like separations 
running through and do not appear as cohesive as the WT control image (Figure 14). Similarly, 
the LCs/interstitial cells are not as aggregated as the WT control, there is evidence of LCs 
detaching from the interstitial mass (red arrowhead).  
 
The HET + EDS treated testis images in Figure 14 display interstitial cell masses which are 
uncharacteristic of WT testis interstitial cell mass features. Normal structure and morphology 
can be seen in the WT control image (Figure 14). In the HET + EDS1 image, vasculature can 
be seen running through the center of the mass (green arrowhead). 
 
The LCs in HET + EDS2 image appear poorly organized surrounding the central vasculature 
(blue arrowhead) and morphologically less round and more elongated than that of the WT 
images. This is of close resemblance to the morphology of LPCs or pericytes (Figure 10), 
potentially suggesting an incomplete maturation through to ALC stage. This may be due to 
failed proliferation as there are also fewer LPCs observed, this would be in support of the 
results observed in the RT-qPCR where no increased expression of Nestin was seen, indicative 
Figure 14 – H&E stain of day 14 testes morphology in different treatment groups from EDS 
study.  
LC population and seminiferous tubule structure appear regular in WT control. Structure of LCs 
appear to degrade with EDS treatment in WT sample, and worsen with EDS treatment in HET. 




of no proliferation of LPCs. These results together can contribute to the explanation suggesting 
a reduced expression of Lhx9 may contribute to the lessened regenerative capacity of LCs. 
 
The testis dissected from the various treatment groups were stained using a NESTIN antibody. 
The results imaged in Figure 15 display the subtle changes which can be seen in NESTIN 
expression. Though all expression is localized to the interstitial cell masses, it is particularly 
noticeable how dark the staining in the HET + EDS treatment is (Figure 15C & F).  
 
The staining in the WT panels A, B, D, and E are all stained evenly, in comparison the HET + 
EDS treated stains. The HET + EDS treated testis stain was uneven and more evident in certain 






Figure 15 – NESTIN specific IHC on day 14 testes from EDS study.  
The WT control images (A&D)  show staining in the interstitial cell masses where LPCs would 
be found, the staining is also present in WT + EDS. Staining appears darker and more 
concentrated in HET + EDS slide.  
Fig A-C images at 20x magnification, scale bars 100 m. Fig D&E imaged at 40x magnification, 
scale bars = 100 m. Fig E imaged at 60x magnification, scale bar = 100 m. Abbreviations: 
EDS = ethane dimethanesulfonate, HET = Lhx9+/-/  
WT CONTROL 
 
WT + EDS 
 
HET + EDS 
 A. B. C. 
D. E. F. 
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Neurofilament heavy peptide (NF-H) is a co-expressed marker of LPCs with Nestin, therefore, 
an IHC was performed to visualize the staining of an additional marker (Figure 16). The 
staining can be seen as even and localized in the interstitial cells where LPCs are located. The 
staining in the EDS treated WT shows an equally even staining, however also shows darker 
staining of an elongated cell (red arrowhead, Figure 16), this is likely a LPC based off the 
morphology (Figure 1). 
 
 
The secondary antibody control image shows there is non-specific staining present in the 
absence of a primary antibody, this is likely due to damaged tissues which trap the secondary 
antibody resulting in precipitation forming, alternatively, blood on sections can result in the 
release of endogenous peroxidases. The endogenous peroxidases may not be entirely 
suppressed by the concentration of hydrogen peroxidase used in the protocol, and therefore 
will not be properly blocked and cause non-specific staining (Kim et al., 2016). Additional 











Figure 16 – NF-H specific IHC on day 14 testes from EDS study.  
Neurofilament heavy peptide (NF-H) is a LPC marker co-expressed with Nestin. The WT control 
image displayed localised staining in the interstitial cells where LPCs are located. WT + EDS image 
shows darker staining on elongated cell, a potential LPC. Secondary Antibody (2 Ab) control image 
demonstrates background staining trapped under cells which are damaged in absence of primary 
antibody. The HET + EDS staining is therefore likely to be a combination of normal expression 
staining in the LPCs and darker staining from damaged cells.  
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3.4. RNA Sequencing Data 
Six samples of RNA were extracted (see 2.5) from HET and WT 3-4-month-old adult testes. 
The quality of the RNA was checked using a nanodrop blanked against 1L of RNase-free 
water, results can be found in Table 8. RNA of good quality can be indicated through the 
measurements from the nanodrop. For good quality RNA, we expect a 260/280 figure of 
approximately 1.8-2, where the closer it is to 2, the “purer” the RNA is. A 260/230 number of 
2-2.2 can be expected for a high level of RNA purity.  
 
RNA samples were then sent to BGI sequencing Hong Kong (see 2.10) for further quality 
analysis before library construction. The data returned from BGI contained RNA Integrity 
Numbers (RIN) shown in Table 8. The RIN number acts as a measure of quality, the scale 
ranges between 1 – 10, 10 being the least degraded and therefore the highest quality (Schroeder 
et al., 2006). 
 
Table 8: RNA sample nanodrop results and sequencing RIN results for samples sent for RNA 
sequencing. 
Sample Nanodrop Concentration 
(ng/L) 
260/280 260/230 RIN Number 
T4m 12390.2 2.02 1.74 8.4 
T601 17580.6 1.85 1.94 8.5 
T602 14884.8 1.98 1.98 8.8 
T50 2428.9 2.03 2.17 9.1 
T66 1568.4 1.97 1.05 3.1 
T67 1267.5 1.97 0.94 2.4 
 
Of the six samples sent for sequencing, only four were of high enough quality to continue 
sequencing with (Table 8). Two samples T66 (RIN 3.1) and T67 (RIN 2.4) were not of high 
enough quality as they had particularly low RIN numbers compared to the other samples such 
as T50 (RIN 9.1). 
 
Bioanalyser results produced from BGI sequencing additionally provides information on the 
quality of the RNA. An example set of results can be found in Figure 17. The graphs can be 
interpreted through two key regions on the x-axis, the baseline signal (25 on x-axis), and the 
18S to 28S ribosomal band region (approximately 2000 on x-axis) (Mueller et al., 2004). The 
peaks expected to be found in high quality RNA are seen in sample T50 of Figure 17.  
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There are two peaks at the 18S – 28S region, and one small peak at the baseline. The smaller 
the baseline signal peak is, the higher quality the RNA is, this is the reason sample T50 only 
has a RIN of 9.1, not 10, as there is a peak present at the baseline. The more degraded the RNA 
is, the closer to the baseline signal the peaks get and the larger the baseline signal peak 
becomes, this can be seen in sample T67. The gel electrophoresis image column on the right 
of the graph is another indication of degradation, the more degraded RNA becomes, the smaller 
the bands fragment into and thus the further down the column they will travel. Sample T67 
displays a smeared column with a single band resting close to the baseline signal (green band) 
indicating the degradation of RNA. Sample T50 however shows a definitive band halfway 
down the column, exhibiting non-degraded RNA (Mueller et al., 2004). 
 
  
Figure 17 – Example Bioanalyser results.  
With the degradation of RNA, the 18S and 28S ratio (region around 2000 on x-axis) decreases, 
and signal at baseline marker RNA increases (25 on x-axis). Sample T67 (Top) displays low quality 
RNA (RIN = 2.4). Band on gel electrophoresis column on right can be seen as degraded. Graph 
shows lack of peaks at  the 18S and 28S points. Sample T50 (Bottom) displays high quality RNA 
(RIN = 9.1), band can be seen midway down gel electrophoresis column indicating RNA has not 
degraded. Graph shows two peaks at 18S and 28S indicting high-quality non-degraded RNA.   
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 Quality Check 
The four samples of RNA quality were used to prepare a library and sequenced using a pipeline 
of online tools (Figure 18) This involved using a series of online tools from Galaxy.  
 
 
The reads produced were mapped against the reference mouse genome (mm10 assembly) using 
HISAT tool. The sequencing returned approximately 23 million reads, 93% of which were 
uniquely mapped to the reference genome. The final table of aligned reads can be found below 
in Table 9. 
 
Table 9: Table of mapped reads from sequencing output generated by BGI.  
RNA sample FastQC file ID Clean Raw Reads Mapped Reads % Uniquely 
Mapped 
WT_2 T4m_2 24489305 22 673 252 92.6 
T4m_1 
WT_1 T601_1 25653754 23 965 844 93.2 
T601_2 
HET_2 T602_1 25727527 23 924 079 93.3 
T602_2 
HET_1 T50_1 25604916 23 542966 91.9 
T50_2 
Transfer files to galaxy
•Filezilla
•Transfer files to galaxy




•Feature count to count reads mapped to genes
•Generation of a count table for each sample
Combine counts
•Combine count columns for each sample to one column
•Downloaded and ready for differential gene expression calling
Figure 18 – Pipeline figure of steps involved with processing RNA sequencing output.  
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Following on, the quality of the sequences was then checked against the FastQC tool on Galaxy 
and shown to be of high quality (Figure 19). Figure 19A is a visual representation of quality 
across all bases. The bases were all within the green zone of the quality check graph, falling no 
lower than the quality score of approximately 30 for each position in the read, an indication of 
high quality. Figure 19B graphs the quality score distribution across all sequences, the average 





Figure 19 – Example of FastQC quality check results for sample T50.  
A. Checking sequence quality per base, all bases are in the green zone above quality score 30 
therefore are high quality zones for each position in the read. B. Quality score distribution across 
all sequences graphed, where average quality per read peaks around 35-38 on the Phred score, 
indicating high quality.  
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 Analysis 
A PCA plot was generated to visualise the amount of variation between the samples and within 
each sample group (Figure 20A) using RUVSeq R package. The sample groups (HET and WT) 
are displaying variation between them which is expected as they are samples of differing 
genotypes. There is clustering appearing within the replicates of each sample group, this is 
indicative that there is consistency within each of the genotypes but variation between them.  
 
 
The differentially expressed genes were called using the edgeR package with a false discovery 
rate (FDR) of 0.1 due to the small sample size. The volcano plot generated was a visual 
representation of DEGs which are differentially expressed between HET and WT samples, this 
was calculated by fold change (FC) compared to expression value (counts per million, CPM). 
The DEGs which were significantly differentially expressed (FDR < 0.1) are shown as a red 
dot on the volcano plot (Figure 20B).  
 
A. B. 
Figure 20 – RNA-seq analysis for differential gene expression.  
A. PCA plot displaying variation between the sample groups and between replicates, HET and WT sample 
groups have a large variation (99.85%), where there is clustering with minimal variation within the 
replicates in the sample groups, HETs cluster together with each other and WT cluster together, maximum 
variation of 0.08%. B. Volcano plot illustrating the differentially expressed genes in HET  samples relative 
to WT by fold change. Red= significantly DEG (FDR<0.1). Data provided by Dr Megan Wilson.  
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Of the significant DEGs, 30 genes were expressed higher in the HET (positive FC), and 21 
were expressed lower in the HET (negative FC). A table of differentially expressed genes was 
generated with their assigned ENTREZ ID numbers (Table 14 & Table 15; Appendix 5). The 
ENTREZ ID numbers were translated into a list of official gene symbols and names, this list 
was then used for gene ontology (GO) analysis. Prior to the GO analysis, the gene list was split 
into two lists, one for each of the genes with higher expression in HET or higher expression in 
WT. The top genes with reduced expression in HET samples can be found below in Table 10, 
and top genes with increased expression in HET samples in Table 11.  
 
Table 10: Top 4 genes with reduced expression in HET samples compared to WT, sorted by FC in 
expression 











factor 1 (Fgf1) 
Key regulator of lipid metabolism (Jiang 






Catalyses production of bicarbonate 
necessary for optimal sperm motility and 





   
7SK small nuclear 
ribonucleoprotein 
(Rn7sk) 
PGC growth and proliferation in testis 





RIKEN cDNA Prominent foetal testis marker 
(O’Shaughnessy et al., 2003). 
 
Table 11: Top 4 genes with increased expression in HET samples compared to WT, sorted by FC in 
expression 
Gene ID log2(fold 
change) 
edgeR  
adjusted   
P-value 
(FDR) 
Gene symbol/name Known role in the testis 
232413  -2.0734481  0.0038083  C-type lectin 
domain family 12, 
member a (Clec12a)  
Low levels of expression in the testes, 
expressed in macrophages/immune cells 
(Marshall et al., 2004). 
100042355  -2.0681159  1.23E-11  predicted gene 
10705 (Gm10705)  
Not been studied in any detail. Low levels 
of expression previously detected in testis 
(Papatheodorou et al., 2020). 
100736249  -2.0288927  0.07342035  mistral long non-
coding RNA (Mira)  
Found within HOX complex (Clark et al., 
2016). It has not been studied with respect 
to adult testis. 
22526  -1.981199  0.00118482  predicted gene 4836 
(Gm4836)  
Not been studied in the testis. Located on X 
chromosome (Clark et al., 2016). 
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BigWig data tracks were produced using the DEG list and visualized in the UCSC genome 
browser, example tracks in Figure 21 display the mapped reads of the DEGs specifically for 
two genes, Rn7sk (top), and Fgf1 (bottom). There is a clear difference in the number of reads 
mapped against the WT samples than the HET.  
 
For each of the DEG lists, two overrepresentation tests were performed using two different 
online GO tools, DAVID (Huang et al., 2009) and Panther (Thomas et al., 2006). For the list 
of genes with lower expression in the HET samples relative to the WT, both overrepresentation 
tests from the two GO tools provided the same results. The results discovered that from the 
genes identified from the ENTREZ ID numbers, the biological pathways significantly 
overrepresented appear to be involved with the lipid metabolism pathway. The table generated 
from DAVID (Table 12) is inserted as an example. 
 
Table 12: Results from DAVID overrepresentation test. 



























de metabolic process 
2 6.896551724 0.04021377 20249, 
13106 
4.64E+01 
Figure 21 – Mapped reads in relation to Rn7sk and Fgf1 genes in UCSC genome browser.  
Reads mapped against Rn7sk (top) and Fgf1 (bottom) both more prominent in WT samples than HET 
samples. HET = Lhx9+/-. Data is shown as bigwig data format. 
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There were no significantly overrepresented biological pathways found in the genes higher 
expressed in HET testis than WT. This is likely due to the small number of genes differentially 
expressed higher in HET.  
 
 Validation 
To validate the levels of expression from the results in section 3.4.2, primers were designed for 
two of the genes significantly differentially expressed between the HET/WT samples. these 
primers were then used to validate the results through RT-qPCR using different biological 
replicates to the RNA sequencing samples.  
 
Of the primers ordered, only one set was efficient at 120%, this was for fibroblast growth factor 
1 (Fgf1). The Fgf1 mRNA expression levels were then quantified in 4-month-old HET/WT 
samples different to the samples sent for RNA sequencing.  
 
 
Figure 22 displays the results from the RT-qPCR quantification, the results indicate a 
significant -1.3-fold difference (p = 0.025) in expression of Fgf1 between HET and WT 
samples. The RNA sequencing data also displayed a significant 2-fold difference (Table 10). 
 
Figure 22 – Results of relative gene expression of Fgf1 to validate RNA sequencing data.  
Validation completed using different biological replicates to RNA sequencing samples. Gene 
expression results from RT-qPCR assay measured against reference genes (Rps29 and Actb). 
Mean of the relative expression, error bars represent standard error of the mean. WT (n = 4), 
HET (n = 3). Statistical significance determined by unpaired t-test. *p<0.05. Fgf1 = Fibroblast 
growth factor-1, HET = Lhx9+/-. 
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Additionally, expression of Fgf1 was quantified in the day 14 EDS treated mice (Figure 23) as 
it is a gene which is differentially expressed in Lhx9+/- RNA-seq data (Table 10).  
The expression of Fgf1 is highest in the WT Control (no injection, day 0 tissue collection) and 
WT no EDS samples (vehicle injection; Figure 23). In comparison, Fgf1 expression is lower 
in both the WT EDS day 14 treatment and in the HET EDS sample. 
 
FGF1 is a promoter of LPC proliferation but not differentiation, the reduction of Fgf1 
expression is likely to be required to enable differentiation of LCs (Chen et al., 2019). Based 
on this knowledge we can expect the overall expression of Fgf1 transcript to reduce at day 14 
given the LCs are forming from the LPCs. The EDS treated WT and HET mice both have lower 
expression of Fgf1 than both WT control (day 0) and WT with no EDS (vehicle) treatment. 
This is expected as EDS reduces the LC populations. The lower expression in the HET EDS 
treated sample was also expected as it begins with a lower baseline expression of Fgf1 than 
WT samples as discovered in the RNA sequencing data (Table 10). The results from this 
quantification are interesting and warrant further experiments to increase the sample size and 
ensure it is reproducible. 
 
 
Figure 23 – Relative gene expression of Fgf1 in preliminary day 14 EDS study samples.  
RT-qPCR assay was normalised against reference genes (Rps29 and Actb). Where WT control = 
Day 0, and other treatment groups (WT no EDS, WT + EDS, HET + EDS) are day 14. Preliminary 
study therefore n=1 for all treatment groups. Abbreviations: Fgf1 = Fibroblast growth factor-1, 
EDS = ethane dimethanesulfonate, HET = Lhx9+/-.  
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4. Discussion  
With the ongoing rise in fertility difficulties in men, the issues uncovered with earlier 
developmental stages of the male reproductive system become more prominent. There is 
already ample understanding about the testes and the associated genetic components, however 
there is much more to be explored, for example the impact of Lhx9 on the development of the 
testosterone producing Leydig cells. This project aimed to investigate the broad hypothesis that 
reduced expression of Lhx9 would lead to a smaller Leydig progenitor cell pool, potentially 
being the cause of reduced fertility observed previously (Wilson, unpublished data). The 
research conducted in this project has begun to prove the Lhx9+/- mice trend towards smaller 
progenitor cell pools, and therefore we can assume that correlates with less adult LCs maturing, 
and predict reduced testosterone causing subfertility. Blood was collected to test testosterone 
levels but due to the shortened project time frame, this had to be left out. 
 
RT-qPCR results revealed changes in overall patterns of Leydig cell marker expression. There 
was a general trend of decreased LPC marker genes mRNA such as Nestin and Notch, alongside 
a general significant difference between the expression of steroidogenic enzyme markers in 
WT and HET samples.  
 
Preliminary EDS injection experiments similarly show changes in the expression of progenitor 
cell pool markers and steroidogenic markers between experimental WT and HET mice. The 
conclusions which can be drawn are however limited due to n=1 and time restraints, this study 
needs to be replicated with a larger sample size.  
 
RNA sequencing results identified 51 genes which were differentially expressed between the 
adult WT/HET samples. An overrepresentation test performed during the gene ontology 
analysis uncovered an overrepresentation of the differentially expressed genes in pathways 
associated with lipid metabolism. Fgf1 was of particular interest as it is a known promoter of 
LPC proliferation (Chen et al., 2019).Validation of this analysis for Fgf1 confirmed a 
significant decrease in the HET expression (Figure 22).  
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4.1. Expression of Key Genes during Leydig cell Development  
RT-qPCR was carried out on the Lhx9 WT RNA extracted from mouse testes of different 
developmental stages ranging from embryonic day 15.5 to adult aged. The aim of this was to 
observe the global gene expression of a number of key marker genes of Leydig cells. 
 
Progenitor cell pool markers such as Nestin and Notch play a role in the maintenance of the 
LPC pool. With this knowledge, the decline in expression of such markers between the post-
natal/pre-pubertal period is unsurprising. One of the reasons being the increasing number of 
ALCs, which the LPCs differentiate into around that developmental period (Zirkin et al., 2010).  
 
With the decrease in LPCs around the pubertal period we can expect this naturally implies there 
is an increase in ALC population. The steroidogenic enzyme markers increase over the 
developmental period to peak at the adult stage where the LCs are most active. This occurs as 
the reproductive peak where functions such as spermatogenesis are most crucial. This aligns 
with previous research indicating that there is an increase in steroidogenic function and a 
decrease in proliferative function along the developmental timeline (Ye et al., 2017) justifying 
the decrease in Lhx9, Nestin, and Notch, and the increase in 3HSD, and P450c17.  
 
Interestingly, the expression pattern of 3HSD differs from that of P450scc though they are in 
the same pathway (Figure 24). 3HSD begins with lowest expression in the E15.5 samples, 
progressively increasing with development, but still having peak expression occur in the adult 
tissues. Though there is no data for one timepoint in P450c17, it can still be observed that the 
peak expression occurs in adult tissues (Figure 6).  
 
The expression of P450scc interestingly does not display a dosage dependent-like pattern 
across the developmental timeline, the literature however suggests there is a decrease in 
expression of P450scc before returning to high expression levels as an adult post-puberty (Hu 
et al., 2007). The results of the P450scc expression pattern can therefore be expected. Based 
on the pre-existing knowledge regarding the developmental timeline of LCs, it is known that 
LC populations decline at birth, and increase again at puberty for the production of testosterone 
necessary for reproductive function (Zirkin et al., 2010). With the known steroidogenic 
function of P450scc, the depleted expression at P0 from E15.5 can be linked to the degenerating 
FLC population, while expression reaches a high in the adult testis (Figure 6). This could 
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possibly be a correlation with the increase in demand for steroidogenesis as the testosterone 
requiring biological processes become active. The proportional increase in testosterone 
synthesis with LC differentiation has been previously explored in the literature to be a result 
of enzymatic activity including P450scc and P450c17 (Shan, 1993). This is indicative that the 
enzymes may play different roles through the developmental period, however are all expressed 
highest in adulthood when reproduction is expected.  
 
The expression of Lhx9 compared to the steroidogenic enzymes do not resemble each other’s 
patterns, but appear inverse. The peak expression of Lhx9 occurs at P0, this timepoint coincides 
with the peak of LCs needed for the activation of androgen responsiveness in the 
hypothalamus. The responsiveness is crucial at that point in development as it an important 
period for the development of secondary sex characteristics highly driven by testosterone (Nef 
& Parada, 2000). This decline of Lhx9 is likely a result of the decrease in the Lhx9 expressing 
progenitor population guiding the necessary differentiation into mature LCs occurring 
(Clarkson & Herbison, 2016; Zirkin et al., 2010). 
 
 
4.2. Impact of Lhx9+/- Haploinsufficency 
RT-qPCR and RNA sequencing were carried out on WT and HET samples at two timepoints, 
E15.5 and adult stage tissues. This was to quantify marker genes which would indicate whether 
the LPC pool size changed based on genotype as hypothesized. 
 
 E15.5 Samples 
The results of the differentially expressed genes illustrated the changes which occurred 
between the E15.5 WT and HET mice.  
 
Firstly, the significant decrease in the LPC marker Notch and trending-towards significant 
decrease of Nestin in HET mouse was interesting. This observation supports the hypothesis 
suggesting reduced expression in Lhx9 reduces the LPC pool (Figure 7). Nestin differential 
expression was not significant, however could be due to sample size (Figure 7). Given the 
established roles of markers Nestin and Notch in the progenitor cell pool, the prominent 
decrease provides evidence contributing to the hypothesis whereby reduced Lhx9 results in a 
smaller LPC pool. 
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Similarly, with the established roles of the steroidogenic enzymes, the decrease in HET 
P450scc expression was not surprising as we can understand how less LCs directly lead to less 
production of testosterone.  
 
The opposite significant increase in 3HSD and P450c17 HET samples was however 
interesting as it was expected to follow the same trend of P450scc as they are part of the same 
pathway as seen in Figure 24. The action of the enzymes is sequential (Martin & Touaibia, 
2020). This raises the question as to whether Lhx9 has a specific region of the steroidogenic 
pathway in which it targets, potentially downstream of the P450scc action which may 
contribute to a reduction in fertility in the affected mice.  
 
 
Alternatively, the increase in 3HSD and P450c17 which opposes the decrease in P450scc 
could be considered a physiological attempt at compensating for the decrease in production of 
pregnenolone to maintain a normal production of testosterone. This pathway can have a large 
impact on the development of individuals. It has been discovered previously in literature that 
a deficiency in pregnenolone due to a heterozygous mutation in P450scc was found in 
genetically 46 XY female. It was discussed that this mutation in P450scc resulted in 
phenotypical sex reversal (Tajima et al., 2001).  
 
Understanding the potential downstream effects which reduced Lhx9 enables allows us to 
consider biomedical applications in which the information can be proactively applied. As for 
the example mentioned, the expression of Lhx9 could be investigated for any heterozygous 
mutations which may develop a link to upstream causes of mutations in P450scc. 
Figure 24 – Basic steroidogenic pathway.  
The simplified steroidogenic pathway for testosterone production, primarily occurring in the LCs. 
Orange arrows indicate direction of change of gene expression in HET compared to WT; decreased for 
P450scc and increased for P450c17 and 3HSD. 
Enzymes involved in process are in orange text, by-products are in black text. Where DHEA = 
dehydroepiandrosterone. 17HSD was not investigated in this study however is integral to the process. 
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The increase in expression is interesting as it would be expected that the downstream enzymes, 
3HSD and P450c17, would have lower expression levels than the upstream P450scc if the 
target of Lhx9 was in the pathway between P450scc and P450c17 (Figure 24).  
 
Genetic markers Pdgfra and Vcam were significantly increased in HET samples. Pdgfra plays 
a role in the differentiation of LPCs (Odeh et al., 2014). It has been previously established in 
literature that the absence of Pdgfra eliminates the ability to form ALCs (Gnessi et al., 2000), 
with this knowledge, there could be many reasons as to why there is such a significant 
difference in expression between the two genotypes. One possibility includes the sudden 
overexpression in the HET samples in attempt to match the expected levels of differentiated 
LCs needed, with attempts to match the essential level of testosterone production for optimal 
reproductive function.  
 
With Arx being another positive factor for LPC differentiation (Miyabayashi et al., 2013), the 
expression was trending towards significantly decreased, this was surprising given the two 
markers are both markers of proliferation. Comparing these two results, we can consider 
whether it is a possibility that they are acting in the same pathway as the target of Lhx9 leading 
to the differing changes in expression. 
 
Lifr expression is increased in the HET mice (Figure 9). Lifr signaling has been characterized 
as a regulator of testicular function, with the primary source being from peritubular myoid cells 
(PTMCs) (Curley et al., 2018). PTMCs are Nestin-positive cells found in the testes which give 
rise to LCs (Kumar & DeFalco, 2018). The decrease in Nestin indicates what is an assumed 
decline in LPCs, this would be expected to lead to a decrease in the expression of Lifr being 
expressed. The expression differences of Lifr are counterintuitive and would be interesting to 
further research.  
 
4.3. EDS Injection Study 
The process of LC regeneration was studied through the elimination of the population by 
injection of EDS. The results (Figure 12) were indicative that there was high expression of 
Nestin, Lhx9, and 3HSD in the day 14 WT EDS treated mouse group. The strong increase in 
these factors in the WT EDS treatment group is likely an indication of the superior regenerative 
ability in the WT mouse versus the HET.  
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The regeneration of LCs begins with regeneration and proliferation of the LPCs to renew the 
progenitor pool from which the LCs will differentiate (Chen et al., 2017). The increase in 
Nestin and Lhx9 is likely the quantifiable proof which illustrates the increase in LPCs and the 
beginning of differentiation into ALCs which can be identified by the increase in steroidogenic 
enzyme 3HSD. Additionally, the increase in 3HSD can also account for the functional 
differences between the EDS treated WT and HET. There is less expression of these three 
markers in the EDS treated HET samples, the decrease in expression can be linked back to the 
hypothesis suggesting the reduced starting LPC pool size which comes with less Lhx9. With 
less LPCs to begin with, it is likely there is less potential proliferation and differentiation for 
the same developmental window than the WT samples with an assumed full LPC pool. The 
expression of Nestin, Lhx9, and 3HSD in the WT control is low, but present. This could be as 
they were not treated with EDS, thus there was no elimination of LCs. With this, we can 
consider there was therefore no regeneration required and so the expression levels were neither 
elevated as the WT EDS treated group, or as reduced as the WT control group because the 
necessary ALCs were already differentiated and stably functioning.  
 
Expression between the three EDS treatment groups for Notch and P450scc are all relatively 
similar to each other. Based on the results mentioned above, we could expect that the 
expression for P450scc to be higher in the WT EDS treatment group. Though it is not, the low 
expression of Notch can be justified. Notch expression has been established as responsible for 
the maintenance of the LPC state (Tang et al., 2008), the decrease in expression observed could 
therefore be correlated to the increase in differentiation in the WT EDS treated mice, the more 
differentiation into ALCs which occurs, the less Notch which will be required to hold the LPC 
state.  
 
The SV weights were also measured to get an interpretation of how the function of the LCs are 
working, the results did not show any notable differences between the treatment groups, this 
could very likely be a result of a lack of replicates.  
 
 Cell Characteristics following EDS Treatment 
The H&E staining of the EDS samples revealed interesting characteristics (Figure 14) between 
the WT and HET EDS treated testes. LCs surround a central blood vessel due to their ability 
to stimulate angiogenesis and the vasculature as a source of their LPCs (Collin & Bergh, 1996). 
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From this, we can expect healthy LC masses to appear as elongated LPCs surrounding 
vasculature with mature LCs also in the population. This is as they appear in the WT control 
image of Figure 14. The WT EDS image displays cells appearing to lose their adhesive 
properties (Lin et al., 2008), the red arrowhead draws attention to the LC which is dissociating 
from the mass. The seminiferous tubules also appear to be affected, displaying less abundance 
of cells within the lumen. This however still appears healthier than the HET treated samples. 
The HET EDS treated testis display a lack of organization surrounding the central vasculature, 
the cells are displaced in the interstitium and appear poorly with more elongated cells than the 
WT, and the seminiferous tubule appear to lack a distinctive lumen.  
 
The elongated cells resembling LPCs (Figure 1) potentially suggest successful proliferation of 
LPCs, but failure to continue development through maturation. With the understanding of the 
presence of Lhx9 in the LPCs (Birk et al., 2000), the reduced expression is more likely than not 
to be involved in the poor physical health of the testicular cells, potentially impacting the 
maturation process more than the proliferation and differentiation.  
 
A NESTIN IHC was performed to visualize the location of expression in the testis. There was 
an abundance of background staining and so was difficult to conclude, however it can be 
acknowledged that there was particularly concentrated staining in the HET EDS treated 
sections. It is known that IHC staining can become particularly dark in dying tissue (Kim et 
al., 2016). IHC staining with NF-H was more successful, with some staining of elongated cells 
(same morphology of LPCs) near the regenerating LC populations were observed in the 
WT+EDS samples.  This staining was not detected in the HET+EDS or WT control samples, 
possibly eluding that the HET struggles to proliferate and mature new cells from LPC to ALC. 
This aligns with the observations made in the H&E staining (Figure 14).  
 
This portion of the study needs to be repeated as it can be difficult to distinguish between 
pericyte cells and LPCs through H&E staining. This is due to morphological similarities 
between pericytes associated with the blood vessels, and LPCs which similarly are detached 
from the blood vessels. A stain specific for LPC markers such as NESTIN or NF-H would be 




4.4. RNA Sequencing 
Six samples were sent to BGI for sequencing, two of which were lacking in quality and 
therefore could not be sequenced (Table 8). The RIN numbers were not high enough and 
showed much of the RNA was degraded. The nanodrop values (260/230) attained prior to 
sequencing were poor, this could have been a result of poor RNA extraction (Table 8).  
 
The results from the sequencing output from BGI sequencing were aligned to the reference 
mouse genome, there were high levels of mapping, all of which were >90% uniquely mapped. 
 
The PCA plot generated to check the variability between the four sequenced samples was 
expected. The clustering of the HET and WT biological replicates within each sample groups 
indicated the replicates were similar enough (Figure 20). Most of the sample variation (98.8%, 
Figure 20A, x-axis) was between the HET and WT sample groups as anticipated.  
 
The decreased expression of Fgf1 in HET samples was validated by RT-qPCR on separate 
biological replicates (Figure 22). This was fascinating to discover given the already established 
roles of Fgf1 in lipid metabolism and its localized expression in the LCs (Jiang et al., 2013). 
The role of Fgf1 is to provide the LCs with the synthesis of testosterone precursor, cholesterol 
(Figure 24), the cholesterol can then be converted into testosterone and used for other 
biological processes such as spermatogenesis and bone maintenance (Ferlin et al., 2013; Jiang 
et al., 2013; Struik et al., 2019; Wang et al., 2015). The decrease in Fgf1 expression in the HET 
samples as a result of a decreased Lhx9 expression in the mice is a viable explanation. Based 
on the hypothesis formed, less Lhx9 could result in a reduced expression of Fgf1 further 
downstream, leading to less cholesterol synthesis and therefore less testosterone synthesis 
contributing to subfertility. The relationship between Lhx9 and Fgf1 could be further 
investigated, specifically whether Fgf1 is directly downstream of Lhx9.  
 
The results from the preliminary EDS study displayed similar trends of expression from the 
Fgf1 RT-qPCR assay (Figure 23). The EDS treated HET sample appears to have a reduced 
expression of Fgf1 compared to the WT control and vehicle. The levels of expression are 
very similar to the WT EDS treated levels. It would be expected that the HET and WT EDS 
treated expression would differ due to the difference in Lhx9, however n=1, thus the sample 
size is very restricting for forming conclusions. Based off the results, it would be interesting 
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to prolong the time allowed for regeneration to exceed 14 days as this may have an impact on 
the results between the WT EDS and HET EDS expression levels. Regardless, the overall 
trend of Figure 23 support the findings that reduced Lhx9 expression is potentially linked to a 
decline in Fgf1 expression, and potentially acting in the same pathway.  
 
It is important to recognize that LCs do degenerate both overtime and with age (Beattie et al., 
2015), to manage this, the day 0 WT vehicle administered mice can act as a control, in 
comparison to the day 0 WT control, there is little difference in the amount of Fgf1 expression, 
and thus implies the decrease in expression is likely a result of the Lhx9 reduced.  
 
4.5. Significance 
With the increasing infertility rates and approximately 40-50% of global infertility rates a result 
of male factors (N. Kumar & Singh, 2015), it is an area of biological research which demands 
more attention. Clinical uses for LC regeneration have already begun to be investigated for 
issues related to adult-onset hypogonadism with hopes to increase testosterone production 
(Lamb, 2019).  
 
Additionally, developmental abnormalities related to mutations in LHX9 have been recently 
discovered, with links to disorders of sex development (DSDs) (Kunitomo et al., 2020). LHX9 
has also been linked to cancer in a number of cases. For example, FGF has been discovered to 
induce LHX9 and further regulate the progression of osteosarcoma (Li et al., 2019). Though it 
is not yet directly linked to testicular cancer, it is interesting that the gene regulating LHX9 in 
osteosarcoma progression (FGF), is from the same family as Fgf1, the gene found most 
differentially expressed in a reduced Lhx9 testis (Table 10). The LHX9 promoter has also been 
found to have increased methylation in cervical cancer (Bhat et al., 2017). With a more 
comprehensive insight into the mechanisms of LC development and regeneration, it is 
unquestionable that research regarding FGF1 and LHX9 is likely to have great biomedical 
relevance, and a myriad of not only DSDs, but also testosterone deficiency related issues could 
be relieved (Kunitomo et al., 2020). With enough development, the mechanisms involving 
specific genes such as LHX9 and FGF1 may even be transferrable across human diseases 




Whilst a fulfilling year was carried out, it must be acknowledged that there are several 
limitations which have hindered carrying out this research to its full potential. Firstly, the 
obvious time restraints caused by the global pandemic this year very suddenly stripped crucial 
time from this tightly planned project. The loss of time was not only inclusive of the 4-week 
lockdown, but also the additional restrictive access to the laboratory during level 3.  
 
With regards to the project itself, there are few flaws to be mentioned. Regarding the Leydig 
cell elimination study, there is only partial elimination in mice, where most studies induce near 
complete elimination in rats, this however could not be avoided as a mouse line was the model 
organism to be used. Additionally, the mouse line used does not generate a Lhx9-/- knockout 
(KO) line as it is embryonic lethal (Workman, Wilson, pers. comm.). This is unfortunate as it 
would be beneficial to understand the expression profile across all three genotypes. One 
possible solution is to generate a conditional-KO line where Lhx9 is knocked out in the testis, 
post-gonadal formation. This however was not possible based on the short timeframe given to 
complete this project.  
 
The staining in the NESTIN IHC revealed issues regarding background staining. To obtain 
more precise knowledge on the location of expression of NESTIN, ranging conditions of 
staining such as differing buffers and blocking times could contribute to more solid results for 
analysis.  
 
Finally, the RNA sequencing data only enabled two replicates rather than the standard 
minimum of three. This was likely due to poor RNA extraction technique of the poor-quality 
samples. The RNA sequencing validation required more RT-qPCR validation than the single 
Fgf1 gene. This was however unavoidable as the primers designed for the other DEGs were 








4.7. Future Direction 
There is great potential in this project based on the results obtained in this short period. There 
is much more to potentially invest time into exploring. To begin, the investigation of LPC 
marker gene expression in Lhx9+/- testes could be more comprehensively mapped if expanded 
into additional timepoints, specifically prenatally and beyond 3-4 months of age in adulthood. 
Similarly, for the EDS LC elimination study, it would be intriguing to further observe effects 
of changes in gene expression for the regeneration of LCs beyond 14 days, and with more 
replicates.  
 
To further develop the RNA sequencing results, the investigation of the relationship between 
Lhx9 and lipid synthesis in the LC steroidogenic pathway would provide great insight into the 
underlying mechanisms of testosterone synthesis and LC regeneration. It would be interesting 
to complete more replicates to potentially observe differences in lowly expressed genes. This 
would enable validation of more genes that can be classed as differentially expressed in the 
bioinformatics. From this, direct targets of LHX9 could then be determined through chromatin 
immunoprecipitation, where LHX9 protein binding sites would be identified.   
 
Samples for the measurement of serum testosterone levels between Lhx9+/- and WT mice were 
collected through the duration of this project as it was initially to be done by an ELISA assay. 
This is important as testosterone is the direct quantifiable product of the LCs and would be 
indicative of differences in functionality between the genotypes. Unfortunately, due to the time 
restraints placed on this project, this experiment was not able to be carried out but must be 
considered for future direction. 
 
Finally, though not the focus of this study, the compelling observation of faint LHX9 
expression in spermatogonia (Figure 5) could be further investigated. Given that LHX9 is also 
expressed in primary oocytes (Workman, unpublished), it would be fascinating as to uncover 





To conclude, this research into the role of Lhx9 in the testis has contributed to a greater 
understanding of the underpinning mechanisms whereby reduced Lhx9 negatively impacts 
fertility.  
 
The results from this research have demonstrated factors which may contribute to subfertility 
in HET mice, more specifically, downregulation of Leydig progenitor cell markers (Nestin and 
Notch), and changes in steroidogenic enzymes, both of which indicate a decrease in progenitor 
cell population as hypothesised. From the RNA sequencing data, we observe 51 differentially 
expressed genes such as Fgf1 between the WT and HET samples. The biological processes 
overrepresented in these genes were involved in lipid metabolism pathways. Finally, 
preliminary LC elimination studies using EDS additionally show interesting changes in the LC 
marker genes, these are promising results for further pursuit.  
 
These results have contributed to defining the genetic network which underlies the 
development and function of testes. This is vital, as a comprehensive understanding of male 
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Appendix 1: Buffers and Solutions 
 
10x PBS  
18.6 mM Na2H2PO4 
84.1 mM Na2HPO4 
1.75 M NaCl 
Diluted to 1x with dH2O (1:10)  
For PBT add 0.025% Tween-20  
 
2% Agarose  
2 g molecular grade agarose  
100 mL 1x TAE buffer  
Dissolve in microwave  
Cool, add 4 L RedSafe  
 
50x Tris-acetate-EDTA (TAE) buffer  
49 mM Tris base  
20 mM acetic acid  
1 mM EDTA  
in H2O  
Diluted to 1x with ddH2O (1:50)  
 
Sodium Citrate buffer  
2.94 g Trisodium citrate 
Make up to 1 L with H2O  
Adjust pH to 6.0 with 1M HCl  
 
Proteinase K Buffer  
2.5 mL Tris-Cl pH 7.5 
0.5 mL EDTA 






2.5mL Tris pH 8 
0.093g EDTA  
0.585g NaCl 
100 L SDS 
Make up to 50mL with water 




Appendix 2: RT-qPCR Primer Sequences 
 




Gene Target Forward Primer (5’ – 3’) Reverse Primer 
3-HSD CCAGGGAGCAATTCTTCAACCT GTGGATAACAACAGAGATGCCC 
Actb GGCTGTATTCCCCTCCATCG CCAGTTGGTAACAATGCCATGT 
Arx GAGCTCCGGCTGAGGAGA TCTCAGAGCAGCCCTCTTCC 
Fgf1 AGGATCCTTCCTGATGGCAC GGTGTCTGCGAGCCGTATAA 
Lhx9 GCCAAGGACGGTAGCATTTA AGCTCAGATGGTAGACAGAGT 
Lifr GACTGCTCCTTCAGGACTGC GAACACAGTTTCCACCAGCC 
Nestin TTTCCTGACCCCAAGCTGAAG GGGTATTAGGCAAGGGGGAAG 
Notch ACAGTGCAACCCCCTGTATG TCTAGGCCATCCCACTCACA 
P450c17 GAGTTTGCCATCCCGAAGGA GAAGCGCTCAGGCATAAACC 
P450scc GGCACTTTGGAGTCAGTTTA CACCTCTTGGTTTAGGACGA 
Patched1 GGCCCCGGGAAATTAATAAAAGG CCAGTAGCCTTCCCCATAGC 
Pdgfra GGAACCTCAGAGAGAATCGGC CATAGCTCCTGAGACCCGCT 
Rps29 TGAAGGCAAGATGGGTCAC GCACATGTTCAGCCCGTATT 
Vcam TACTGTTTGCAGTCTCTCAAGC CGTAGTGCTGCAAGTGAGGG 
 73 






















































Appendix 5: DEG List from RNA-Seq Analysis 
 
Table 14: DEGs higher expressed in HET samples (FDR < 0.1) 
ENTREZ_GENE_ID logFC PValue FDR 
232413 -2.0734481 2.65E-06 0.0038083 
100042355 -2.0681159 8.59E-16 1.23E-11 
100736249 -2.0288927 0.00017559 0.07342035 
22526 -1.981199 7.25E-07 0.00118482 
20359 -1.9495702 8.83E-05 0.05145929 
17068 -1.7726812 0.0001074 0.05679469 
14129 -1.7470464 0.00014873 0.07037115 
100504361 -1.6050829 0.00024542 0.09193148 
12608 -1.5640013 7.06E-06 0.00705331 
12310 -1.5540218 0.00021638 0.08645482 
68195 -1.324456 4.88E-05 0.03376457 
12259 -1.2446698 3.62E-05 0.02710474 
11522 -1.2440153 6.75E-05 0.04335703 
80891 -1.221175 1.02E-05 0.00912645 
100271704 -1.2164418 0.00022788 0.087178 
30794 -1.1973013 0.00025125 0.09219362 
75140 -1.1102941 9.30E-05 0.05145929 
665155 -1.1052984 6.09E-05 0.0405286 
66995 -0.9990849 0.00017102 0.07342035 
68267 -0.9940838 0.00016913 0.07342035 




Table 15: DEGs lower expressed in HET samples (FDR < 0.1) 
ENTREZ_GENE_ID logFC PValue FDR 
13984 0.76937415 9.44E-05 0.05145929 
20249 0.82276239 2.69E-05 0.02106363 
14600 0.90228994 0.00018334 0.07492095 
277468 0.91229317 0.00022697 0.087178 
100862375 1.0576976 0.00013148 0.06566652 
57390 1.09129466 0.00025762 0.09264095 
16011 1.15840785 3.68E-06 0.00440579 
67522 1.17727851 3.66E-06 0.00440579 
258438 1.22328913 0.00014815 0.07037115 
14311 1.25714774 0.00016961 0.07342035 
73889 1.26070128 2.41E-05 0.01966604 
11770 1.43711508 3.49E-10 1.26E-06 
619991 1.44524338 2.75E-06 0.0038083 
15439 1.52733748 6.90E-07 0.00118482 
16956 1.53285835 1.02E-07 0.0002045 
69629 1.58412382 0.00026846 0.09464673 
231004 1.67026852 5.78E-06 0.0061164 
110257 1.69838116 5.06E-06 0.00568701 
13106 1.77812954 1.88E-09 4.83E-06 
75342 1.84156136 0.00012634 0.0649028 
11537 1.92374945 4.30E-11 1.93E-07 
100502669 2.03654264 9.34E-05 0.05145929 
100038453 2.15098014 0.00017468 0.07342035 
19817 2.15890725 1.24E-14 7.46E-11 
71052 2.17282964 1.17E-05 0.01001389 
14164 2.19943599 7.77E-06 0.00735727 
100038508 2.36930831 4.51E-05 0.03242912 
170942 2.40110091 3.59E-08 8.07E-05 
12350 2.42206893 1.37E-15 1.23E-11 
380994 2.80536032 5.43E-10 1.63E-06 
 
